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Gut represents a complex landscape in which commensal bacteria, harmless antigens and food 
proteins are strictly in contact with the immune system that has to be able to maintain a balance 
between the immune response and tolerance. In this context, mononuclear phagocytes are the most 
abundant population and macrophages represent a key player in this process of discrimination by 
allowing a peaceful coexistence. If this crucial checkpoint is lost, immune system is activated and falls 
in a dangerous and prolonged inflammation. Recent studies have described CX3CR1+ cells as a 
population of resident macrophages able to sample the gut lumen and to produce the anti-inflammatory 
cytokine IL-10 in order to maintain homeostasis. These macrophages are characterized by the 
expression of the chemokine receptor CX3CR1; however, how this receptor is involved in the 
molecular mechanisms that regulate the inflammatory response is largely unknown. 
The global aim of this thesis is to define the role of mucosal CX3CR1+ macrophages during 
acute and chronic inflammation and in the process of intestinal carcinogenesis, and to investigate the 
molecular mechanisms by which these immune cells maintain gut homeostasis.  
We analyzed the behavior of these macrophages in mice lacking the CX3CR1 receptor 
(CX3CR1GFP/GFP) and in wild type heterozygous mice (CX3CR1GFP/+). Firstly, we characterized them 
as a macrophagic population expressing CX3CR1, F4/80, CD11b and CD64 confirming the data 
present in literature.  
As the behavior of these cells is less defined during the resolution of inflammation, we 
performed a model of recovery from colitis and we found that KO mice displayed higher signs of 
inflammation compared to WT mice, and they were not able to recover as WT mice did. From the 
molecular point of view, we found that the inflammatory mediators were up-regulated in KO mice as 
well as members of the IL-10 family cytokines. The only mediator resulting down-regulated in KO 
mice was heme-oxygenase-1 (hemox-1). 
Hemox-1 is an anti-inflammatory enzyme over-expressed during tissue injury that is able to 
promote bacteria clearance. This regulation of this molecule is very complex and involves also IL-10. 
However, despite KO mice produced more IL-10, in an attempt to switch off inflammation, they were 
not able to produce an adequate amount of hemox-1. 
We reproduced, in vitro, the model of colitis and we showed that macrophages from KO mice 
responded to the inflammatory stimulus (LPS) with an aberrant response, up-regulating both pro and 
anti-inflammatory mediators, but not hemox-1. Moreover, we observed a synergism between LPS and 
the chemokine Fracktalkine/CX3CL1 (FKN) in the production of hemox-1 in WT mice and also found 
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that stimulation with FKN alone was sufficient to produce hemox-1 in WT mice, unveiling a previously 
unidentified role of the chemokine receptor CX3CR1 in the regulation of hemox-1.  
Using the AOM/DSS model of colitis-induced carcinogenesis (CAC), a study that has never 
been performed in these genetically modified mice, we found significantly higher signs of inflammation 
in KO mice in terms of both cytokine production and immune cell infiltration, as well as higher score 
of tissue damage and number of polyps. Also in the CAC model, KO mice attempt to switch off 
inflammation by over-producing IL-10 levels; furthermore, hemox-1 was under-expressed. We 
therefore decided to enhance hemox-1 production using cobalt protoporphyrin IX (coPP), a 
compound able to stimulate hemox-1 in the intestine. The experiments revealed that treatment with 
coPP was able to revert the phenotype in KO mice, resulting in marked lower inflammation and 
reduced tumor load. To corroborate these findings, we investigated a genetic model of intestinal 
tumorigenesis (APCmin mice) and generated APCmin CX3CR1GFP/+ WT mice and APCmin CX3CR1GFP/GFP 
KO mice. Also in this tumor model, mice deficient for the CX3CR1 receptor demonstrated higher 
inflammation, lower Hemox-1 and more extensive tumorigenesis, thus overall confirming the results 
obtained with the sporadic CAC model. 
Hemox-1 acts on macrophages by stimulating the processes of phagocytosis; accordingly, we 
found that  bacteria phagocytosis was significantly impaired in KO mice. The sequencing of the 
microbiota in the stools of mice treated with the AOM-DSS model, revealed a different microbiota 
composition, in particular, Akkermansia were down represented in KO mice. Akkermansia is reported to 
be impaired during inflammatory bowel diseases, leading to the rise of other bacteria and to an overall 
dysregulation of the total microbiome composition.  This dysbiosis might be involved in disease relapse 
and rise of chronic inflammation that can lead to cancer development.  
Overall, we unveiled a new pathway by which intestinal CX3CR1+ macrophages operate to 
maintain gut homeostasis. If the CX3CL1-CX3CR1 checkpoint is lost, the FKN-induced production 
of hemox-1 is missing and an aberrant inflammatory response could persist and be corroborated by a 
state of dysbiosis. In this landscape, chronic inflammation and the impaired resolution could, over time, 
promote tumor development.  Finally, we confirmed that treatment with the chemical compound 
coPP up-regulates hemox-1 also in the absence of functional CX3CR1 receptor, and drastically 
ameliorates the intestinal disease. These findings open a new scenario in the use of hemox-1-inducing 
drugs to restore the correct intestinal homeostasis in a therapeutic context. 
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 Mucosal immunology 
 
The intestine is an exclusive tissue able to maintain balance between the immune 
system activation and the tolerance against the very huge amount of harmless antigens that are 
in contact with the intestinal lumen, including food antigens and microflora. 
It is fundamental for our health that our immune system is able to respond with a robust 
and appropriate response to potential dangerous antigens, but the same reaction against 
harmless antigens, like commensal bacteria or dietary proteins, could be very dangerous and 
could give rise to allergies or chronic inflammation that, in the end, can lead to tissue damage 
or cancer development.  
Many immune cells participate to the maintenance of the homeostasis in gut, with the 
role of understanding how an antigen is a potential danger for the organism and being silence 
in response to commensal bacteria and food antigens. This complex landscape includes T and 
B lymphocytes, natural killer cells, innate lymphoid cells, eosinophils, mononuclear 
phagocytes among which dendritic cells and macrophages.  
Innate lymphoid cells (ILCs) are a subset of immune cells of lymphoid origin that, 
differently from lymphocytes, do not express antigen-specific receptors but act quickly upon 
cytokine stimulation. There are three different subpopulations of ILCs that mirror the T helper 
classification: ILC1, ILC2, and ILC3. ILC1s are present in the lamina propria and, as Th1 
lymphocytes, act via T-bet; they are able to produce TNF-α and IFN-γ in response to 
intracellular pathogens. ILC2s are involved in the response against helminth and in the allergic 
reactions and are implicated in wound healing. They mirror the Th2 response and they activate 
GATA-3, upon stimulation by IL-25 and IL-33, with the consequently production of IL-4, IL-
5, IL-13, IL-9 and IL-6. ILC3s are able to activate RORγt and show a heterogeneous behaviour. 
They produce IL-17a, IL-22 and TNF-α and are involved in the control of commensal bacteria 
and in the repair of lymphoid tissue. ILC3s are the most abundant ILCs in the gut. They are 
able to interact with epithelial cells and other mucosal immune cells in order to cooperate in 
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the control of gut homeostasis. Bacteria in the lumen activate epithelial cells and CX3CR1+ 
macrophages (Mφ) that sample the lumen and play a key role in the maintenance of 
homeostasis. However, microbe-associated molecular patterns (MAMPs) can migrate into the 
Payer’s patches and can activate CD103+ DCs that migrate into the lymph node where they 
activate B and T cells. ILC3s actively participate to the formation of Payer’s patches and isolated 
lymphoid follicle (ILFs). Here APC, T and B lymphocytes orchestrate the immune response. 
In this context, ILC3s are able to induce B cells in the ILF to produce IgA, with consequent 
mucosal protection [1]. IgA are produced by B lymphocytes that, in the intestine are specialized 
in the production of this type of immunoglobulin. IgAs are secreted and act as a wall to protect 
the intestinal epithelium from antigens. Here, IgAs can bind microbiota and food antigens, 
reducing their access to the bloodstream thus being able to control microbiota. Recent works 
have demonstrated that IL-10 and TGF-β can promote IgA secretion in the gut [2]. Moreover, 
IL-10 a key factor in the maintenance of the gut homeostasis, can be produced also by particular 
B cells called Breg. Breg production of IL-10 is an important trigger for Treg generation [3]. 
In the gut, the T cell mediated response plays a crucial role: when the epithelium is 
damaged, several molecules are released in order to activate the correct immune reaction and 
to protect the mucosa. Naïve lymphocytes are recruited from thymus and bone marrow and 
are able to enter in contact with the gastrointestinal tract via GALT (gut-associated lymphoid 
tissue). This process is mediated by the expression of complementary trafficking receptor on 
both endothelial and immune cells among which CCR7-CCL21, CXCR4-CXCL12, CXCR5-
CXCL13: CCR9-CCL25 [4]. Once arrived in the secondary lymphoid tissues T and B naïve 
cells enter in contact with APC and are available for activation. The temporary expression of 
chemokines and chemokine receptors is fundamental for gut homeostasis: for example, the 
CCR6-CCL20 axis is able to recruit T lymphocytes into the lamina propria. In particular CCR6 
is expressed mostly by Th17 lymphocytes. Of note, CCL20 is expressed by the intestinal 
epithelium only during inflammation. Instead, in healthy tissue, CCL20 expression is 
negligible, highlighting the fine temporary and spatial regulation of lymphocytes recruitment 
[5]. Another trigger example is given by IL-33. This cytokine is a member of the IL-1 family 
and can act as alarmin inducing the mucosa wound healing or can act as a potent inducer of 
inflammation. Recent studies have shown how this mechanism occurs: If IL-33 is localized in 
the nucleus, it is able to act as alarmin, otherwise, the loss of nuclear sequestration leads IL-33 
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to be released into the systemic circulation, inducing inflammation via activation of Th2 
responses [6]. Indeed Th2 lymphocytes express the IL-33 receptor ST2 and its signalling induce 
the typical Th2 transcription factor GATA-3. An additional key factor in Th2 response is 
adenosine and its receptor A2BAR. It has been shown that the absence of this receptor impairs 
the Th2 cascade decreasing the recruitment of M2 Mφ and eosinophils.  
Another important T subpopulation is composed by T regulatory cells (Treg) 
characterized by the expression of CD4, FOXP3 and CD25. It is important to note that Treg 
can modulate the immune response in gut not only acting in the lamina propria but also 
inhibiting T cell activation in lymph nodes. Treg express high level of ST2 being able to sense 
IL-33 that plays as alarmin. During inflammation, IL-33 is able to activate Treg cells in order 
to restrain intestinal inflammation. In this context it has been shown that IL-2 produced by 
APC is able to increase Treg response to IL-33 while IL-23 is able to limit their function 
highlighting the complex regulation of the inflammatory response in gut [7].  
Overall, it is evident that the intestinal immune system plays a complex and crucial role 
in the maintenance of this balance. In this landscape, mononuclear phagocytes have a central 
part in the process of discrimination and allow a peaceful coexistence. It is important to note 
that these cells, and in particular macrophages, are able to maintain the immune system silent 
but, in case of need, they are able to trigger and to sustain the immune response (figure 1). 
Fig.1: Many immune cells participate in the maintenance of homeostasis in the intestine [1] 
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Characterization of mononuclear phagocytes in gastrointestinal tract 
Mononuclear phagocytes can be detected in the entire gastrointestinal tract, in 
particular in the lamina propria, close to the epithelial monolayer [8]. Two main populations of 
mononuclear phagocytes are present in gut: dendritic cells (DC) and macrophages (Mφ) and 
they represent the most abundant leukocyte population in the gut and the largest population of 
macrophages in the entire body. Unfortunately, it is not easy to classify these cells into a specific 
category. It is important to be able to distinguish between the different subsets of DC or Mφ, 
in order to study the ways by which they can maintain homeostasis or switch to inflammatory 
programs. If we can do it, we will be able to clearly identify a specific subset and, consequently, 
to study its mechanism of action and, in the end, to target it. For this reason, many efforts have 
been done in order to identify surface markers able to distinguish between DC and Mφ.  
Considering mice, two different markers are used to differentiate mononuclear 
subsets: CX3CR1 for macrophages and CD103 for dendritic cells. CX3CR1 expression is not 
a feature of all tissue resident macrophages, for instance, Langherans cells, lung alveolar or 
epidermal macrophages do not express the receptor, on the contrary, microglia in the central 
nervous system and kidney macrophages do it [9]. Moreover, resident macrophages do not 
always express the same level of CX3CR1: it has been reported [10] that a population of 
CX3CR1int macrophages is able to expand during colitis. Bain and colleagues demonstrated 
that Ly6Chi monocytes give rise to all different types of macrophages in healthy colon and 
during colitis and that CX3CR1int cells represent a pool able to generate inflammatory or 
resident macrophages, depending on signals in the milieu. Similarly, in another study, Bain et 
al. [8] focused on the DC marker CD103, which can be used to define DC subsets in the 
gastrointestinal tract, expressing or not CD103. Considering this complex landscape, it is 
difficult to properly define the different subpopulations of mononuclear phagocytes present in 
the intestine. For this reason, other markers are used to characterize DC and Mφ. For instance, 
for resident macrophages, CD64 can be used in combination with CD11b, F4/80 and CX3CR1 
[10, 11]. Fortunately, this classification seems to be valid also for human phagocytes. In 
particular, in association with classical markers such as CD68, CD163 and MHCII, CX3CR1 
has been shown to be expressed by intestinal macrophages even in humans.  
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Macrophages can also be classified on the basis of their functional polarization into two 
major subtypes: M1-classicaly activated- or M2-alternatively activated. M1 macrophages are 
pro-inflammatory and sustain immune response, while M2 macrophages limit inflammation. 
However, this classification is difficult to apply to intestinal resident macrophages: they fail to 
express arginase that is considered a paradigm of M2 polarization and they produce IL-10 
together with TNFα [12]. Despite this, M1 and M2 classification do not want to be a narrow 
organization, but describe a spectrum of a continuum that, sometimes, can be hard to be 
translated in vivo. 
 
Ontogeny of resident macrophages  
Macrophages in the intestinal mucosa are considered mononuclear phagocytes that 
originate from a common myeloid progenitor which can differentiate also in dendritic cells or 
granulocytes. This progenitor gives rise to a common precursor of both DCs and monocytes 
[13]. In mice, monocytes in the intestine were initially divided into two different subsets, 
depending of the expression of the combination of two markers: Ly6Chi-CCR2hi monocytes 
were considered inflammatory cells while Ly6Clow-CX3CR1hi monocytes were considered the 
precursors of resident macrophages. Nowadays this classification is considered obsolete and 
not more valid. The majority of monocytes in blood express high levels of Ly6C and CCR2 
and it has been shown that mice lacking the CX3CR1 gene do not fail to accumulate 
macrophages in tissues. Therefore, it has been proposed that classical monocytes (Ly6Chigh) can 
generate both inflammatory and resident macrophages while non-classical monocytes expressing 
low levels of Ly6C and CCR2 but high level of CX3CR1 are proposed to maintain the 
vasculature integrity and to phagocyte in the blood stream [14-16]. In humans it has been 
reported the same behaviour of macrophage precursors and gene expression analyses revealed 
many parallels between human and mouse monocytes [17].  
Monocytes in the gut have a different origin compared to precursors in other tissues. 
Many studies showed that lung alveolar Mφ, Langherans cells, microglia, Kupffer cells and 
Mφ of the peritoneal cavity derives from embryonic precursors. In yolk sac or the fetal liver 
and colonize tissue early in development and maintain themselves during life by in situ 
7 
 
proliferation [9, 18, 19]. Bain et al., [10] demonstrated that intestinal mouse macrophages are 
continuously replenished from blood stream monocytes. He showed that Ly6Chi monocytes 
are recruited in the mucosa and here, in five days, they differentiate in mature macrophages 
progressively loosing Ly6C and starting to express F4/80, CD64, MHCII and CX3CR1. In the 
same way he demonstrated that macrophages in the adult gut have a very poor proliferative 
rate (figure 2). 
 
Fig.2: Ontogeny of mucosal macrophages [8] 
 
For their recruitment monocytes need the CCR2-CCL2 axis. It has been shown that 
mice lacking either CCR2 or CCL2 fail to accumulate macrophages in the mucosa. However 
it is not completely clear how monocytes are recruited in the adult mucosa as CCR2-/- or 
CCL2-/- mice are not totally devoid of intestinal macrophages [20]. It has been proposed that 
other mediators such as TGF-β or CXC-chemokines can have an active role in this process but 
further studies are needed to better clarify this issue [21]. However, the meaning of this 
continuous replenishment is still under investigation: why does the mucosa need to incessantly 
replace its mononuclear phagocytes is unknown. A possibility is that this change is required to 
constantly monitor the persistent exposure to the commensal bacteria and food antigens; in 
fact, recent studies have reported that germ free mice show an impaired number of 
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macrophages in the colonic mucosa [22] highlighting the importance of controlling the 
relationship between homeostasis and microbiota.  
 
Function of resident macrophages in the healthy mucosa 
Resident macrophages are located in the lamina propria, in tight contact with the 
enterocytes that compose the crypts. As other tissue macrophages, in the gut, the main role of 
these cells is to execute several housekeeping functions as tissue remodelling or clearance of 
apoptotic cells. Moreover intestinal macrophages are able to produce several factors among 
which PGE2 that have a central role in the maintenance of tissue homeostasis allowing the 
differentiation of local epithelial progenitors to enterocytes of the crypts, regulating, in this 
way, the integrity of the epithelial wall [23]. Resident macrophages also play an important role 
in the phagocytosis of luminal bacteria and they show an efficient bactericidal capability [24]. 
Considering that resident macrophages express high levels of MHCII, it has been proposed that 
they can serve as antigen-presenting cells. Rescigno et al., demonstrated the role of CX3CR1 
cells in the activation of CD4 T lymphocytes: Mφ can not migrate to the lymph node but 
CX3CR1 is fundamental to capture and to transmit the antigen to the dendritic cells that are 
able to migrate to mesenteric lymph nodes (MLN) [25]. In addition to this, they express high 
levels of MHCII but the exposure to antigens or bacteria does not trigger any pro-inflammatory 
response in these cells. This is achieved by the production of the anti-inflammatory cytokine 
IL-10. As a matter of fact, gut resident mecrophages in steady state produce both IL-10 and 
TNFα, thus maintaining the immune system in a state of “alert anergia”, unable to trigger a pro-
inflammatory response but predisposed to be activated in case of emergency. In support to this 
evidence, germ free mice produce less amount of IL-10 [22]. 
Considering that many other tissue macrophages do not express CX3CR1, it seems 
clear that this receptor is induced by the local microenvironment of the gut and that it plays a 
central role for intestinal macrophages. Which could be the process inducing CX3CR1 is still 
controversial: it has been proposed that TGF-β could be a candidate as well as CX3CL1. 
However, recent data demonstrated that CX3CR1-/- and WT mice have the same anatomical 
distribution of intestinal macrophages, excluding the CX3CR1-CX3CL1 axis in this type of 
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regulation [26]. On the contrary, TGF-β is very abundant in steady state but it seems that its 
main role is the maintenance of the hyporesponsiveness to different Toll like receptors (TLRs) 
in the healthy mucosa [27]. However, gut macrophages express normal levels of TLRs in both 
mice and humans. Many efforts are done in order to better understand the mechanisms behind 
the unresponsiveness of these cells. The main hypothesis is that the molecule downstream of 
the TLR could be the target of the regulation. In fact, if MyD88 is downregulated in intestinal 
resident macrophages, the molecules that inhibit the TLR signalling seem to be upregulated in 
these cells [28, 29].  
Another function of intestinal Mφ, recently proposed, is that these cells facilitate the 
secondary expansion of T regulatory cells by the production of IL-10 [30]. Finally, it has been 
proposed that CX3CR1 is required for transepithelial dendrites (TED) formation. The 
mechanism proposed is that intestinal macrophages can acquire luminal bacteria by extruding 
TED across the epithelial barrier and maintaining homeostasis by the production of IL-10. 
However, recent studies were in contrast with these results and demonstrated that there were 
no TED in the healthy mucosa and that the uptake of lumen antigen was independent of the 
CX3CR1-CX3CL1 axis [31-33]. 
  What seems to be a robust founding is that intestinal macrophages are able to maintain 
homeostasis in the gut by the production of IL-10. Recently, Zigmond et al., demonstrated 
that IL-10R is fundamental for gut Mφ to sense IL-10. If the receptor is lacking, these cells are 
able to produce but not to sense IL-10. It has been proposed that an IL-10-based autocrine loop 
acts directly on CX3CR1 intestinal macrophages. Consequently, if cells are not able to detect 
IL-10, the autocrine mechanism of regulation is lost and inflammation can start [34]. 
Importantly, also in humans, IL-10R deficiency is associated with a severe form of intestinal 
bowel disease (IBD) [35]. 
 
Macrophages during intestinal inflammation 
The intestinal leukocyte composition changes drastically during inflammation and, in 
particular, the mononuclear phagocytes play a crucial role in both the early events of 
inflammation and in the processes of resolution. For instance in IBD, in both ulcerative colitis 
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and Crohn’s disease, macrophages are the most abundant population in the mucosa. To 
understand how monocytes and macrophages change their properties during colitis is 
fundamental in order to target these cells for therapeutic purposes.  
In many different mouse models of colitis, is reported that, during inflammation, there 
is a reversion in the ratio of CX3CR1hi and CX3CR1int macrophages. The CX3CR1int Mφ have 
markedly a pro-inflammatory signature: they are able to produce many inflammatory cytokines 
as IL1β, IL6 and IL12 and they express the chemokine receptor CCR2, which allow Ly6Chi 
precursor to enter the tissue and to differentiate into CX3CR1int macrophages [28].  
 
Fig.3: Changes in macrophage landscape during homeostasis and inflammation [8]. 
 
However, as discussed above, Ly6Chi monocytes are the same precursor of both pro-
inflammatory Mφ and resident Mφ. Bain and Mowat [8] proposed that during colitis the 
normal monocyte differentiation process is stopped resulting in the reversed ratio between pro 
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and anti-inflammatory macrophages. Interestingly, resident macrophages are not influenced by 
the change in the microenvironment and continue to exert their anti-inflammatory behaviour 
being unresponsiveness to TLRs stimuli [12]. When the inflammatory insult is finished, 
homeostasis must be restored in order to avoid the emergence of chronic inflammation. In this 
context CX3CR1hi Mφ return to expand to detriment of CX3CR1int Mφ that, progressively, 
are cleared by apoptosis [36]. How these processes take place is not fully understood. Many 
lines of evidence suggest that CX3CR1int Mφ are recruited during inflammation from CCR2+ 
monocytes and differentiate in the mucosa. Here, the CX3CR1hi Mφ maintain their anti-
inflammatory role avoiding the rise of aberrant inflammation and, probably, starting the 
process of resolution (figure 3).  
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Microbiome 
 
Bacteria, viruses, fungi, archea, parasites and phages compose the microbiome that is, 
more generically, the whole collection of microorganisms that resides in a host [37]. Despite 
many species compose the microbiome, bacteria are the most abundant and heterogeneous 
population. This subset of the microbiome, in healthy condition, is exclusively present in the 
mucosal sites and epidermis that are the surface of our body exposed to the external world. 
This is the case of the oral cavity and upper airways, skin, gastrointestinal and reproductive 
tract. To understand the importance of microbiota in human life, it is sufficient to think that 
only bacteria are ten times more abundant compared to host cells and that their metagenome 
is 100 times higher than the whole host genome [38]. Despite this important presence in our 
body, microbiome undergoes very strong selective phenomenon in the mucosal sites and, for 
instance, only nine phyla have been detected in human body, in contrast with twenty observed 
on plant surfaces [39, 40]. However still low is known about the microbiome: it is estimated 
that more than 60% of bacterial species are undetectable for the inability to be cultured and 
the majority of remaining species have a dynamic and complex way to grow, making the 
isolation and reproducibility very difficult. In case of loss of integrity of the body surfaces such 
as in tissue injury and healing, the composition of microbiome changes drastically and, for this 
reason, one of the most interesting field of investigation is how the bacteria composition 
influences the repair of the wound healing.  
 
Intestinal microbiome 
The microbiome of the intestine begins to form at birth. It has been proposed that 
bacteria enter in contact with the host via different ways, for example, skin and fecal microbiota 
of relatives and parents, bacteria from the vagina or from the milk of the mother or thanks to 
the contact with other children [41]. The final composition of bacteria develops during the first 
three years in a multifaceted way that, till now, is not completely understood [42]. What is 
clear is that diet or dietary changes and nutrient availability can influence the composition of 
the microbiome, together with antibiotics or drug administration [43]. The anatomical 
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distribution of bacteria is not homogeneous and it changes in the different parts of the intestine, 
for instance, the most abundant community of bacteria is in the large intestine. The quality of 
microbiome change spatially and also temporally in the gut and is different for each individual. 
This means that the condition of symbiosis, the relationship between the host and his 
microbiome, is different from person to person and, consequently, it is impossible to define a 
universal condition of dysbiosis that occurs when poor nutrition or disease alter the equilibrium 
impairing the function of microbiome [44-46]. During a wound, be it acute or chronic, the 
epithelium of the intestinal wall is destroyed and the quantity of mucus and lipids drastically 
impaired. This condition is able to alter the production of anti-microbial peptides and generates 
inflammation. In this way the mucosal surface is exposed to the environment creating an 
opportunity for non-indigenous bacteria to colonize the site and alter the equilibrium between 
the host and the microbial species [37]. Microbiome in wound repair has been reported to have 
a key role in both resolution of the injury or in the establishment of chronic inflammation, 
depending of the type of microbes. There is evidence that the relationship between microbiota 
and the epithelium wall is one of the essential point during gastrointestinal inflammation. The 
microbiome can influence the microenvironment producing different types of chain fatty acids, 
butyrate and modifying the bile. There are many mechanisms by which microbiome can 
influence the gastrointestinal epithelium repair. For instance, epithelial cells express high levels 
of TLR able to recognize bacterial PAMPS, in other way, the interaction between bacteria and 
epithelium can modulate β-catenin signalling or interact with the induction of NF-κB or ERK. 
However, it is important to remember that inflammation alters the normal epithelium layer 
resulting in a change in microbiome composition that can induce pathology [47-50]. 
 
Intestinal microbiome in IBD 
As said above, the relationship between host epithelium and microbiome is 
fundamental in healthy conditions. During inflammation, things change, and there is a 
deficiency in mucus production that can lead bacteria to infiltrate the mucus layer and spread 
into tissue. Contrary to common thought, during IBD the richness in bacteria species and their 
diversity is reduced and also the stability in the composition of microbiota changes. This has 
been proposed to be one of the possible causes of the fluctuating disease in both Crohn’s disease 
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(CD) and ulcerative colitis (UC) [51, 52]. During inflammation, as it happens in IBD, different 
species of bacteria colonize the gastrointestinal tract and the resulting higher risk of intestinal 
infection may be due to an altered intestinal environment that causes the loss of commensal 
bacteria and provides the colonisation of other species of microorganisms. An explicative 
example is given by Akkermansia, a mucolytic species of bacteria that is impaired during IBD. In 
this case, the loss of Akkermansia results in the rise of another mucolytic species- Ruminococcus 
gnavus- that has been observed in CD and UC and has been associated with a relapse of the 
disease. Moreover, being the mucus the native habitat of many species of bacteria, its alteration 
results also in a dysregulation of the total microbiome composition [53]. Another beautiful 
example is given by Faecalibacterium prausnitzii that is normally present in healthy gut and is an 
abundant butyrate-producer. In patients with UC F. Prausnitzii is decreased in both biopsy and 
fecal samples. In mice, it has been shown that Prausnitzii exerts an anti-inflammatory response 
interacting with NF-Kb and CXCL8 production, so the loss of this microorganism can eliminate 
an early and potentially important anti-inflammatory process [54] (figure 4). 
 
Fig.4: Changes in microbiome composition during IBD [55]. 
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Role of macrophages in bacteria clearance 
How the gut immune system is able to discriminate between pathogenic and 
commensal bacteria is still unknown. Commensal bacteria express many of the molecules also 
expressed by pathogenic bacteria, which are able to trigger the immune system. In fact, it has 
been shown that commensal bacteria that penetrate the epithelial barrier, are able to cause 
inflammation [56]. Despite the commensal role that bacteria have in healthy people, during 
infection or inflammation the “bad-population” of microorganisms have to be eradicated to 
restore the equilibrium. The key role in this complex game is mainly entrusted to macrophages 
and neutrophils. As discussed above, macrophages are recruited to the gastrointestinal tract 
largely thanks to the CCR2-CCL2 axis. Ishida et al., [57] demonstrated that CX3CR1 KO mice 
have impaired anti-bactericidal functions. They showed that macrophages are normally 
recruited in both WT and KO mice but if the CX3CR1 receptor is lacking, bacterial clearance 
is reduced. They supposed that CX3CL1 serves to activate macrophages and, as consequence, 
is able to induce the expression of NO, TNFα, IL-12, IL-1β. These mediators act in a paracrine 
and autocrine manner on macrophages augmenting their bactericidal functions. If cells are not 
able to sense CX3CL1 –as in case of KO mice-, this mechanism is lost and it results in higher 
levels of inflammations. Finally, Mazzini et al., demonstrated the role of CX3CR1+ 
macrophages in priming dendritic cells, highlighting, in a different way, the importance of the 
receptor in the maintenance of homeostasis [25]. 
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Heme-oxygenase-1 
 
Heme-oxygenase (HO) is a microsomal enzyme that is part of the superfamily of heat 
shock proteins. HO converts heme in biliverdin and carbon monoxide (CO) with the release 
of free ferrous iron.  There are two genetically distinct isoenzymes, the inducible form (hemox-
1) and the constitutive form (hemox-2). hemox-1 is expressed by different cell types, in 
particular epithelial cells and mononuclear phagocytes such as macrophages and neutrophils 
[58] while HO-2 is expressed, preferentially, by brain and testis [59]. Hemox-1 is a stress-
responsive protein that can be induced quickly by different stimuli including nitric oxide, heavy 
metals, hemin and reactive oxygen species (ROS) [60] (figure 5).  
 
Fig.5: Induction of heme-oxygenase-1 [60] 
 
It has been reported that the activity of hemox-1 can exert anti-inflammatory activities; 
in particular, biliverdin, the product of hemox-1 activity, has anti-oxidant proprieties that 
reduce lipid peroxidation, have anti-complement functions and reduce the mesenteric 
neutrophil migration and extravasation during inflammation. In parallel CO, the other product 
of hemox-1 activity, is able to down-regulate the expression of pro-inflammatory molecules 
and to modulate the leukocyte-endothelial cell interaction [61]. Moreover, murine 
macrophages treated with lipopolysaccharide (LPS) are able to up-regulate hemox-1 and 
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consequently attenuate the production of many pro-inflammatory mediators such as IL-1β, 
TNFα, IL-6 and cyclooxygenase-2 (COX-2) [62]. Experimental mouse model of hemox-1 
deficiency demonstrated that mice are prone to develop chronic inflammation and are more 
susceptible to sepsis induced by endotoxin. Importantly, the same phenotype has been 
observed in the only event of genetic hemox-1 deficiency identified in humans [63, 64]. Despite 
the relationship between hemox-1 and inflammation is nowadays accepted, the mechanisms by 
which this enzyme exerts its immunomodulatory functions are still under investigation. Lee et 
al., [65] propose that the anti-inflammatory effects of hemox-1 are mediated by IL-10. In his 
work he demonstrated that IL-10 is able to induce hemox-1 in murine macrophages and the 
consequent production of CO is responsible of the anti-inflammatory effects of IL-10 such as 
reduction in TNFα, NO and MMP9 production after stimulation with LPS. Naito y. et al., 
[66] further investigated this pathway and they proposed a complicate relationship in which IL-
10 and hemox-1 reciprocally stimulate each other. They demonstrated that the induction of 
IL-10 after LPS was significantly reduced after administration of zinc protoporphyrin IX (znPP 
IX) an inhibitor of hemox-1. In contrast, the administration of a hemox-1 inducer such as cobalt 
protoporphyrin IX (cop IX) enhanced the IL-10 production. 
 
Heme-oxygenase-1 in the intestine  
Many studies demonstrate that hemox-1 is overexpressed during experimental colitis 
in rats and mice and also in human specimens is possible to detect high level of the enzyme 
[67]. It is well known that in IBD there is a powerful expression of both ROS and iNOS and, 
consequently, of nitric oxide (NO). Whittle b. et al., proposed that the reactive species act 
inducing hemox-1 in an attempt to regulate inflammation during colitis [60]. As said above, 
Lee and colleagues proposed IL-10 as a greater inducer of hemox-1 [68, 69].further 
highlighting the importance of gut microbiota, together with IL-10, in hemox-1 production. 
In fact they demonstrated that microbiota is a fundamental player in this pathway: the 
microbiota is able to induce hemox-1 only in WT mice but not in IL-10-/-mice. Moreover, 
they shown that also zebrafish maintain this kind of regulation, demonstrating that these 
pathways are fundamental and conserved during evolution. To summarize the current 
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knowledge, it seems that hemox-1, and in particular its product CO, has potent anti-
inflammatory properties. The microbiome can induce hemox-1 production activating IL-10 via 
TLR signalling. The consequence of this activation is the stimulation of the production of anti-
inflammatory cytokines and the inhibition of pro-inflammatory molecules such as Il-1β, IL-6 
and TNFα. Finally, the increased levels of CO seems to play an important role in stimulating 
bacteria clearance by macrophages. Therefore, in the intestine, microbiota can act a pivotal 
role in the maintenance of homeostasis stimulating the production of hemox-1. This 
mechanism act as a loop on macrophages in order to make appropriate clearance of bacteria. If 
this mechanism is lost, bacteria are no longer under control and they can invade the mucosa 
and give rise to inflammation [70]. 
 
Heme-oxygenase-1 in macrophage polarization  
In the intestine, the major producers of hemox-1 are macrophages. A lot of effort was 
required in the last years to establish the importance of the hemox-1 pathway in the induction 
of anti-inflammatory stimuli during intestinal injury (figure 6). Next to IL-10 that, as discussed 
above, plays a central role in macrophage life, many other effectors have to be considered. 
Heme is quite known to be a powerful hemox-1 inducer. Macrophages present on their surface 
two distinct receptors for heme that are able to interact with CD163 and to be internalised via 
endocytosis. During tissue injury, very high levels of heme can be released as a consequence of 
haemolysis [71]. Figueiredo et al., [72] proved also that heme can induce hemox-1 transcription 
binding directly TLR4 indicating that the regulation of this enzyme is dependent on heme 
concentration. Finally, several lines of evidence suggest that heme is able to influence 
macrophage polarization, enhancing M2 macrophages and suppressing M1. Another via to 
enhance hemox-1 production resulting in M2 polarization of macrophages, involves 
adiponectin. Recently, Mandal and colleagues [73] described a possible M2 polarization of 
macrophages due to adiponectin effects on hemox-1 expression. They demonstrated that 
adiponectin can stimulate the expression of hemox-1 improving the anti-inflammatory 
signature. Finally, it seems that also diet can promote hemox-1 production and in particular, 
some natural compounds such as curcumin, resveratrol, sulforaphane and agaro-
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oligosaccharides [74]. Notably, it has been demonstrated that agaro-oligosaccharides are able 
to augment the expression of Mrc1, Ym1 and Arg1, typical markers of M2 activation [75]. On 
the contrary, Harusato and colleagues propose the transcriptional factor Bach1 (a key TF for 
macrophages polarization) as a potent suppressor of hemox-1 production. They demonstrated 
that Bach1-/- mice are protected during TNBS-induced colitis in term of both grade of colitis 
and pro-inflammatory cytokine production [76]. In the same way, they proved that the 
administration of a hemox-1 inhibitor such as tin protoporphyrin is able to potentiate the 
colonic damage highlighting the beneficial effect of hemox-1. 
 
Fig.6: Hemox-1 in macrophage polarization [66] 
  
20 
 
Cancer related inflammation  
 
Cancer is a complex multi-step process in which normal cells acquire peculiar traits 
that lead to malignant growth such as self-sufficiency from external signals, insensitivity to 
negative growth signals, resistance to apoptosis, limitless replicative potential, sustained 
angiogenesis, acquisition of tissue invasiveness and metastasis. Virchow, in the 19th century, 
firstly described the link between inflammation and cancer. His intuition was based on the 
observation that neoplastic tissues are infiltrated with inflammatory cells and suggested that 
tumors may arise at sites of chronic inflammation [77]. Nowadays it is accepted that a consistent 
number of malignancies worldwide are related to conditions of chronic inflammation (e.g. 
persistent infections, autoimmune diseases, general inflammatory conditions). Cancer-related 
inflammation (CRI) is currently accepted as a hallmark of cancer (figure 7).  
 
Fig.7: Recently, cancer-related inflammation has been added as a hallmark of cancer. New emerging 
peculiar traits of cancer are the deregulation of cellular energetics, genomic instability and the ability 
to evade immune destruction [77]. 
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CRI is a smoldering, non-resolving inflammation, characterized by the infiltration of 
white blood cells, in particular myeloid cells, the presence of inflammatory mediators such as 
cytokines (e.g. TNF, IL-1, IL-6) and chemokines (e.g. CCL2 and  CXCL8) and the occurrence 
of continuos tissue remodeling and angiogenesis [78]. 
Immune cells are present in the tumor microenvironment from the early stages of 
carcinogenesis and are deeply affected by the presence of cancer cells, which, in turn, are 
influenced by leukocytes in different ways. Innate and adaptive immunity leukocytes have an 
ambiguous link with cancer cells and can either inhibit or promote tumor growth. It is now 
quite clear that the immune system has a defensive role in the first acts of tumor growth and 
actively tries to eradicate those cancer cells that escape the immune surveillance and become 
antigenically “silent”, overgrow, but in the end give rise to clinically evident tumors. At this 
stage, when tumors become detectable, cancer cells have riched a critically great mass and are 
able to affect the immune system. When it happens, immune cells become harmless effectors, 
with immunosuppressive functions and devoid of cytotoxic ability [79]. This process is known 
as “cancer immunoediting” and it was firstly proposed by Dunn and colleagues [80]. Cancer 
immunoediting can be considered as a result of three processes: elimination, equilibrium and 
escape (the “3E” hypothesis). During the elimination phase, the immune system recognizes 
transformed cells and act in order to destroy them. It can release many mediators, cytokines 
and chemokines able to recruit other immune effector cells at the tumor site in order to 
promote cancer cell death. Despite the efforts of the immune system, many neoplastic cells 
can survive the elimination process and enter into a dynamic equilibrium with the host immune 
system.  During this phase, cancer cells modify their antigen expression and acquire different 
mutations that provide them to resist to immune attack. In the escape process, surviving tumor 
variants break the equilibrium evading the immune system that is no longer able to detect and 
to eliminate them. In this way, neoplastic cells are able to expand in an uncontrolled manner 
and the disease becomes clinically evident [80].  
 
 
 
22 
 
The Intrinsic and Extrinsic Pathway 
Two different pathways link inflammation and cancer: the intrinsic and the extrinsic 
pathway (figure 8). The extrinsic pathway is driven by inflammatory or infectious conditions 
that increase cancer risk. On the other side, the intrinsic pathway is activated by genetic 
alterations that lead to a chromosome instability, reactive oxygen species (ROS) production 
and other alterations that can trigger inflammatory mediators and activate the inflammatory 
cascade [78].  
In the intrinsic pathway, when genetic alterations occur (such as mutations 
promoting/inactivating oncogenes and tumor-suppressor genes, as well as chromosomal 
amplification and rearrangement), inflammatory transcriptional programs are activated in 
mutated cells, generating an inflammatory microenvironment. Recent studies [81, 82] showed 
that the activation of the protein kinase RET, due to a chromosomal rearrangement, is 
necessary for the pathogenesis of papillary thyroid carcinoma and directly promotes the build-
up of an inflammatory microenvironment at tumor sites. Moreover, genetic alterations in 
tumor-suppressor genes such as VHL, TGF-β and PTEN can promote the recruitment of cells 
of myelomonocytic origin and represent a link to metastasis and angiogenesis [78].  
In the extrinsic pathway, an inflammatory chronic response may increase cancer risk: for 
example, persistent infection by tumorigenic pathogens, such as Helicobacter pylori or hepatitis 
B (HBV) and C (HCV) viruses, can increase the incidence of gastric cancer, mucosa-associated 
lymphoid tissue (MALT) lymphoma, or hepatocellular carcinoma respectively [83].  
Autoimmune diseases and inflammatory conditions as prostatitis or inflammatory 
bowel disease (IBD) can be also considered as triggers of chronic inflammation that increase 
cancer risk and progression [84].  
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Fig.8: The link between inflammation and  cancer is  described by two converging pathways: the 
extrinsic pathway (activated by inflammatory/infectious  conditions) and the intrinsic  pathway (driven 
by oncogene activation). They both result in cancer-related inflammation and involve transcription 
factor activation, cytokine and chemokine release and the recruitment of infiltrating leukocytes [78]. 
 
Tumor microenvironment 
The tumor microenvironment (TME) is a dynamic milieu composed by stromal cells 
such as fibroblasts, immune cells, soluble factors and extracellular matrix.  The extensive 
communication between the tumor and the stroma provides a tumor niche able to sustain 
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tumor growth, to generate metastasis and to protect the tumor from the immune system. 
Moreover the niche is a controversial milieu responsible, in many cases, of therapy resistance. 
TME is in continuous change: it constitutes a large fraction of the whole tumor, often more 
than half of the tumor mass, and it is able to recruite many types of cells, inducing tissue 
remodeling, antigen changes and metabolic alterations [85]. Cytokines and chemokines are key 
components of the tumor microenvironment. They play a central role in cancer-related 
inflammation promoting the migration, invasion and survival of malignant cells, coordinating 
autocrine and paracrine interactions between tumor cells, and infiltrated leukocytes. Colotta, 
F. et al., recently hypothesized that inflammatory cells and their mediators, such as cytokines 
and chemokines, can contribute to cancer initiation and progression through different 
mechanisms that lead to genetic destabilization of cancer cells including DNA damage or 
alteration of cell cycle checkpoints and DNA repair systems [84]. The high degree of genetic 
heterogeneity in tumors suggests that genetic instability is an ongoing process throughout 
tumor development and that the inflammatory response can accelerate the somatic evolution 
of cancer. In the end, the tumor tissue results as a complex heterogeneous milieu in which 
genetic mutation are melted with genomic instability promoted by inflammatory mediators 
[77]. An additional critical component of the tumor microenvironment is the extracellular 
matrix (ECM), a highly organized three-dimensional structure whose main physiological 
features include: maintenance, tissue integrity, regulation cell migration, cellular 
differentiation and proliferation and provides a reservoir of cytokines and growth factors [86]. 
Five classes of macromolecules including collagen, laminins, fibronectin, proteoglycans and 
hyaluronans compose the ECM that can also be divided into two main groups, the basement 
membrane (BM) and interstitial or stromal matrix. BM is a mechanical barrier composed of 
dense collagen type IV and laminin; it organizes tissue and cell growth and regulates 
differentiation, polarity and gene expression [87]; its dissolution is one of the main features in 
epithelial cancer development. By contrast, the stromal matrix is composed by polysaccharide 
gels, proteoglycans and different fibrous proteins [86].  
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Tumor associated macrophages 
Macrophages are plastic cells derived from monocytes that orchestrate the innate and 
adaptive immune responses [88]. According with Mantovani et al., macrophages can be divided 
into two different subpopulations depending of their functional polarization [89]. M1 classically 
activated macrophages and alternatively M2 macrophages (figure 9). This characterization, 
however, has some limitations and simplifies a complex scenario in which macrophages can 
show features of both populations, depending on the different stimuli they are subdued. M1 
“classically activated” macrophages reflect and sustain Th1 responses. They are polarized by 
cytokines such as IFNγ or by microbial signals. On the other side, M2 “alternatively activated” 
macrophages mirror the Th2 polarization and can be generated in response to cytokines such 
as IL-13, IL-4, IL-10 and TGF-β [79]. 
M1 Mφ are pro-inflammatory cells able to produce TNFα, IL-1β, iNOS and they have 
bactericidal proprieties. M2 Mφ, instead, have immunomodulatory functions through the 
production of IL-10 and TGFβ. They are considered tissue resident and anti-inflammatory cells 
involved in tissue remodeling and angiogenesis [90]. 
 
 
 
Fig.9: Macrophage polarization is driven by cytokines 
 
 
In the tumoral context, Tumor Associated Macrophages (TAM) display a phenotype 
similar to M2 polarized Mφ. They do not exert cytotoxic activity and they actually favor tumor 
growth in a variety of ways, including suppressing the anti-tumoral response, enhancing tissue 
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remodeling and neo-vascularization (figure 10). However, recently, sophisticated analyses 
have revealed an abundant heterogeneity in TAM especially dependent on their localization in 
the tumor microenvironment [91]. TAM mainly originate from monocytes directly derived 
from the bone marrow. However, new evidence suggests a splenic contribution and  to a local 
proliferation [92-94]. Incoming monocytes are preferentially recruited in necrotic or hypoxic 
areas within tumor stroma where they are profoundly influenced by stimuli of the tumor 
microenvironment and quickly differentiate in tumor-conditioned macrophages. Chemokines, 
for example CCL2, CCL5, CXCL12, and growth factors such as CSF-1 (M-CSF) are major 
determinants of monocyte infiltration in tumors. Also cytokines play a crucial role; in 
particular IL-10 and TGFβ can suppress the host immune response making the tumor 
antigenically “silent”. It is believed that in the first step of tumor progression, macrophages try 
to fight against tumor ande exert mainly anti-tumoral functions.  
 
Fig.10: Pro-tumoral function of TAM [79]. 
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However, tumor growth is able to modify the microenvironment enriching it of many 
suppressive molecules such as Th2-related cytokines (IL-4), IL-10 and TGF-β able to “re-
educate” Mφ and allow them to acquire pro-tumoral –M2- functions [95]. In this context, 
TAM release trophic factors able to activate tumoral and stromal cells. TAM are able to 
regulate many aspects of cancer biology, such as tumor cell invasion, angiogenesis as well as 
immunoregulation [88] (fig). Vascularization is fundamental for tumor survival; TAM support 
tumor growth by triggering the acquisition of a vasculature that provides oxygenation and 
nutrition to tumor cells, in a process often referred to as “angiogenic switch” [77]. Indeed, 
TAM are able to promote neoangiogenesis and lymphoangiogenesis by releasing pro-angiogenic 
growth factors such as VEGF-A, VEGF-C, EGF, thymidine phosphorylase (TP) and 
chemokines such as CCL2 and CXCL8 [96]. Hypoxia is the best driver of angiogenesis. In 
tumor hypoxic areas, the up-regulation of HIF-1 and HIF-2 triggers angiogenesis inducing 
TAM to produce several mediators such as VEGF, FGF2, CXCL8 and proteolitic enzymes (for 
example matrix metalloproteinases MMP-1, MMP-7, MMP-9) that induce the ECM digestion 
[97].  
Matrix components in the tumor microenvironment can modulate the pro-tumoral 
functions of TAM. TAM directly support tumor cell survivor and proliferation in a reciprocal 
cross talk. Indeed, tumor cells produce CSF-1 that act on TAM inducing them to secrete the 
epidermal growth factor (EGF), which in turn sustain tumor cell proliferation and migration. 
Macrophages are very important players in tissue and extracellular matrix (ECM) remodeling, 
being the main source of MMPs and other proteolytic enzymes. The destruction of the ECM 
by TAMs favor tumor cell invasion and penetration into vessels and eventually giving rise to 
metastatic dissemination. TAM exert their immunosuppressive role by secreting several factors 
such as IL-10, TGFβ and CCL22 that can suppress CD4+ and CD8+ T cell function directly 
or indirectly. In parallel, through the axis CCL22/CCR4 Treg cells are recruited by TAMs at 
tumor sites. Moreover, they can block tumor regression by inhibiting NK cell recruitment and 
T cell proliferation and activation via the PD-L1/PD1 signaling axis.  
Because high TAM infiltration has been associated with poor prognosis and therapeutic 
failure in cancer patients, reprogramming TAM toward an antitumor M1 phenotype or 
inhibition of their recruitment or suppression may be beneficial in future therapeutic 
approaches. Indeed, in murine experimental settings different strategies have been used to 
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target TAM in tumor, either as therapy alone or combined with conventional or anti-
angiogenetic therapies. Overall, the results obtained are very promising, confirming the 
promoting role of TAM in cancer progression [97]. However, even if TAM acquire M2-like 
features, especially in advanced metastatic tumors, is not unusual to find TAM with a M1-like 
phenotype in particular in early stages of tumor development or in regressing tumors. Thus, 
TAM are very plastic cells that can express both M1 or M2 characteristics depending on the 
stimuli they received from the microenvironment [98].  
 
 
Tumor associated chemokines 
Chemokines are chemotactic cytokines described as soluble mediators originally 
described to promote the directional migration of leukocytes [99, 100].  They are small 
proteins of 8-10 KD and, recently, it has been proposed that not only leukocytes but also 
epithelial and endothelial cells, fibroblasts and neoplastic cells can produce and respond to 
chemokines after particular stimuli, such as tissue injury or infection [101, 102]. 
Chemokines have been classified into four families (CXC, CC, C and CX3C) according 
to the position of cysteine residues in the N-terminal region; a further subdivision is based on 
the presence or absence of an ELR (Glu, Leu, Arg)-motif, located in front of the first conserved 
cysteine residue [103, 104]. All chemokines can exert their functions through binding to seven 
transmembrane G-protein-coupled receptors (CXCR, CCR, CR or CX3CR). The interaction 
of the ligand with the receptor is not unique: many chemokines can bind different receptors 
and viceversa. Despite redundance is a typical feature of chemokines, a small number of 
receptors can bind a single ligand. Moreover, chemokines can also interact with non-signaling 
receptors such as DARC (Duffy antigen receptor for chemokines), D6 or CCX-CKR 
(ChemoCentryx receptor) [105, 106].  
Both receptor and ligand expression is strictly related to the differentiation and 
activation state of the cell and can be expressed either constitutively or after stimulation [107]. 
Another characteristic feature of chemokines is their ability to act in synergy; this means that 
different proteins can affect the same target in order to enhance the response to the stimulus. 
Chemokines are essential in not only pathology but also play an important role in the 
29 
 
maintenance of homeostasis. In steady state they regulate leukocytes trafficking and homing, 
mediate lymphoid tissue organogenesis and regulate hematopoiesis. When a pathological 
condition occurs, chemokines are produced in order to co-ordinate the correct response to 
injury. They are involved in all types of pathological disorders regulating both the pro and the 
anti-inflammatory response, the recruitment of leukocytes, tissue remodeling, angiogenesis 
and can influence cell survival and proliferation. Furthermore, chemokines can be activated 
and involved in processes such as autoimmune diseases (e.g. IBD, rheumatoid arthritis) and 
tumor growth and metastasis [101]. In tumors, chemokines predominantly participate in the 
chemoattraction of leukocytes at tumor sites and modulate tumor behaviour by several 
mechanisms such as activation of a tumor-specific immune response, promotion of the 
angiogenic switch, and stimulation of tumor cell proliferation and metastasis. Moreover, 
genetic mutations (such as in c-MYC gene) and the activation of transcriptional factors (e.g. 
NF-kB, STAT3) trigger chemokine release.  
Thus, chemokines play a crucial role in tumor promotion and development, being able 
to affect the tumor microenvironment in terms of leukocyte recruitment, stimulation of 
angiogenesis, tumor proliferation and matrix remodeling. Chemokines affect tumor 
microenvironment; the ability of the immune system to fight against tumor is consequently 
influenced by chemokines. Pro or anti-tumoral response can differ depending on chemokine 
avaialability. Generally, pro-tumoral responses push leukocytes to produce pro-tumoral 
mediators and viceversa. For instance, that the interaction between ELR+ CXC chemokines 
(e.g. GRO, ENA-78, IL-8, GCP-2) and CXCR1 and/or CXCR2, trigger the infiltration of 
pro-tumoral neutrophils, while CXCR3  binding  ELR- CXC chemokines (e.g. Mig, IP-10, 
PF-4) attracts anti-tumoral DC, T lymphocytes and NK cells. Moreover, many CC chemokines 
(especially CCL17 and CCL22) secreted by macrophages at tumor sites play an active role in 
Th2 and Treg cells recruitment promoting tumor development [101]. Finally, it is important 
to highlight that chemokine receptor can be expressed also by tumor cells. Autocrine and 
paracrine extracellular signals, genetic and epigenetic alterations, can trigger chemokine 
receptor expression that is correlated with an increase in cell survival and spread. Indeed, the 
presence of chemokine receptor such as CXCR4, CXCR1, CXCR2 or CXCR5 on tumor cells 
is related to an increase of invasiveness and metastasis. Muller and colleagues [108] first 
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described how the expression of CXCR4 in neoplastic cells mirrors the risk of metastatis 
development in a model of mammary carcinoma.  
Notably, also in colorectal cancer the presence of the CXCR4-CXCL12 axis is related 
to a worst survival prognosis due to the risk of metastasis. Moreover, Popivanova et al., 
recently demonstrated that the expression of CCL2 correlates with CRC progression. In 
addition, CCL2 antagonists can inhibit COX-2 expression, attenuate neovascularization and 
therefore decrease the number and size of tumors [109]. Another evidence that chemokines 
have a central role in CRC development is given by Erreni M., and colleagues that 
demonstrated the up-regulation of several chemokines (CCL7, CCL20, CCL25, CXCL1, 
CCL26) and their receptors (CCR8, CCR6, CXCR2) in human tumor tissues of CRC [110]. 
Another example that chemokines and their receptors are involved in tumor metastasis is the 
expression of CXCR3, CXCR4 and CCR7 in primary CRC clinically correlates with tumor 
recurrence, patient survival and lymph node or liver metastasis [111, 112] (table 1). 
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Tab.1: Chemokines and chemokine receptors play a crucial role in IBD and CRC development, 
recruiting inflammatory cells [113]. 
 
Fractalkine  
Fractalkine (CX3CL1) is the only member of the CX3C chemokine family. Differently 
from other chemokine, it can exist in two form: as a membrane-anchored molecule or in 
soluble form. This chemokine is firstly synthesized as membrane-anchored form and consists 
of a chemokine domain linked to a transmembrane domain via a mucin-rich stalk of 
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extracellular domain. In the presence of metalloproteases such as ADAM-10/17 or MMP2, or 
in the presence of the protease Cathepsin S, the chemokine domain can be cleaved and the 
soluble form released, exerting its chemotactic activity [114] (figure 11).  
 
 
 
Fig.11: Secondary structure of fractalkine 
http://atlasgeneticsoncology.org/Genes/CX3CL1ID46756ch16q13.html 
 
Many soluble mediators such as cytokines (TNFα, IL-1, IFNγ) or bacterial products 
(LPS) can enhance fractalkine expression in different cell types such as endothelial and epithelial 
cells, neurons, lymphocytes, microglial cells and osteoblasts [115]. Instead, CX3CR1 is mainly 
expressed by macrophages but can be also present on DC, CD4 and CD8 lymphocytes, NK 
cells, neurons, astrocytes and tumor cells. It has been reported in literature that the CX3CL1-
CX3CR1 axis play a critical role in the development of inflammatory diseases: increased levels 
of CX3CL1 have been detected at inflammatory sites in murine models of rheumatoid arthritis, 
asthma, renal disease, chronic liver disease, inflammatory brain diseases and IBD [114]. In 
particular for IBD, the role of this chemokine axis is quite controversial and not deeply 
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clarified. Kostadinova and colleagues suggested a negative role of the CX3CL1-CX3CR1 axis: 
in a mouse model of DSS-induced colitis they show that the absence of CX3CR1 is protective 
for the colonic mucosa.  In particular, they reported that the presence of fractalkine and its 
receptor correlates with an increase in tissue damage and colitis score, promoting the 
recruitment of inflammatory cells, including macrophages. Therefore, they suggest that the 
absence of the axis could protect the epithelium from a massive macrophage infiltration thus 
being protective for colonic mucosa [116]. On the contrary, Medina-Contreras et al., support 
the idea that the CX3CR1-CX3CL1 loop has a protective role in the intestinal mucosa and that 
the presence of the receptor can prevent Th-17 mediated colitis. Moreover, they demonstrated 
that the deficiency of CX3CR1+ macrophages contributed to enhanced colitis in CX3CR1gfp/gfp 
mice [26]. In addition, Longman et al. found that colonic CX3CR1+ mononuclear phagocytes 
regulate innate lymphoid cell production of IL-22 and play a critical role in promoting mucosal 
healing during colitis [117]. Besides inflammatory diseases, the CX3CL1-CX3CR1 axis is also 
involved in cancer pathogenesis. Recently, it has been demonstrated that the presence of 
CX3CL1 positive cells often correlates with an increase of CX3CR1 immune cells in many 
neoplasia such as lung carcinoma, melanoma and gastric carcinoma. On the contrary, in some 
tumors, CX3CL1/CX3CR1 can play a crucial role in tumor angiogenesis, as well as in adhesion 
and migration of cancer cells, triggering their ability to spread and metastasize. For example, 
in malignant breast tissues, CX3CR1 overexpression increases the ability of tumor cells to 
migrate to skeleton and brain where bone stromal cells and neurons release soluble CX3CL1. 
In the same way, in glioblastoma patients it has been demonstrated that CX3CL1 and CX3CR1 
are expressed by both cancer stem cells and progenitor cells, suggesting that this axis operates 
in early tumorigenesis process [118]. In colorectal cancer the role of CX3CL1/CX3CR1 axis 
has been poorly investigated. Zheng et al. found that CX3CR1 is expressed in tumoral cells in 
a histologic grade and stage-dependent manner. In addition to this they showed that CX3CR1 
expression on TAM correlates with worst prognosis. They also highlighted the importance of 
the receptor in macrophage survival demonstrating that CXRCR1+ Mφ are able to regulate 
the tumor microenvironment through the induction of survival stimuli and that the absence of 
the receptor inhibits macrophage infiltration in metastatic tumors through induction of 
macrophage apoptosis [119]. 
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Colorectal cancer 
 
Colorectal cancer (CRC) is a very frequent human neoplasia and represents the third 
most common cause of cancer death in industrialized countries [120]. The pathogenesis of CRC 
is a very complex process that involves both genetic and environmental factors. Considering 
the environmental aspects, alcohol consumption, cigarette smoke, diet, microbial or chronic 
infections are the most common predisposing factors to develop CRC. On the other hand, 
genetic alterations can occur in a sporadic or hereditary manner. Although most colorectal 
cancers are sporadic tumors, about 10% of CRCs are a hereditary disease. Two forms of genetic 
disorder are known: the hereditary non-polyposis colorectal cancer (HNPCC or Lynch 
syndrome) and the familial adenomatous polyposis (FAP). Both HNPCC and FAP are 
autosomal-dominant diseases: FAP is due to a germline mutation in the adenomatous polyposis 
coli gene (APC) while HNPCC is caused by alterations in genes of the DNA repair system (e.g. 
Mismatch repair, MMR) [121].  
 
Fig.12: Colorectal carcinoma development is a multi-steps process involving the accumulation of 
different genetic alterations in colonic epithelial cells [122]  
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In most CRC cases, mutations occur as a multi-steps process that leads to the 
accumulation of genetic alterations in colonic epithelial cells and evolve from a benign adenoma 
to invasive carcinoma (figure 12).  
 Adenoma is an early lesion characterized by highly replicating cells forming a mass that 
protrudes into the lumen. The transition from benign adenoma to invasive carcinoma occurs 
when colonic neoplastic cells overstep the muscolaris mucosa and invade the submucosa, thus 
resulting in an invasive colorectal cancer.  
CRC is characterized by many genetic alterations that can be classified based on the 
DNA damage that they are able to generate: genomic instability (chromosomal instability, 
DNA-repair defects, aberrant DNA methylation), mutational inactivation of tumor-suppressor 
genes (e.g. APC), activation of oncogene pathways (e.g. RAS, BRAF), and alteration of 
regulatory mechanisms in stem-cell and growth factor pathways [123].  The loss of genomic 
stability plays a crucial role in colorectal cancer development by facilitating the acquisition of 
multiple tumor-associated mutations: the two most common genomic instabilities in CRC are 
microsatellite instability (MSI) and chromosomal instability (CIN) (figure 13). 
Fig.13: Schematic representation of the two major pathways (CIN and MSI) involved in CRC 
development and progression [124]. 
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Microsatellite instability is a hypermutable phenotype caused by an expansion in the 
number of tandem repeat sequencings during DNA replication. Loss of the DNA repair system 
activity (Mismatch Repair Gene, MMR) is detected in about 15% of all CRCs [125]. 
Chromosomal instability occurs in 85% of colorectal cancer cases and is characterized by 
widespread imbalances in chromosome number, due to defects in chromosomal segregation. 
The loss of the tumor-suppressing activity caused by mutations in tumor-suppressor genes, 
such as APC, p53 and SMAD4, triggers neoplastic transformation and tumor cell survival, 
invasion and metastasis. The early mutation of APC is the most common initiating event in 
CRC: APC is able to bind β-catenin creating a complex that is degraded in an ubiquitin-
dependent manner. In this way the wnt pathway is inhibited. In the absence of a functional 
APC protein, cellular activation is uncontrolled, wnt signaling is inappropriately and 
constitutively activated and neoplastic colon cells begin to proliferate. Beyond tumor 
suppressor genes, also oncogenes play a crucial role in colorectal cancer occurrence. 
Oncogenic mutations of RAS and BRAF activate the MAPK signaling pathway  and represent 
37% and 13% of colorectal cancer mutations, respectively; furthermore, one third of  these 
tumors bear activating somatic mutations in PI3KCA [123].  
 
Colorectal cancer and cancer related inflammation 
Colorectal cancer is a paradigm of the cancer related inflammation [126] (figure 14). 
Epidemiological and clinical  studies  showed that patients affected by inflammatory bowel 
diseases (IBD) such as Chron's disease and ulcerative colitis (UC) have an higher risk to develop 
colorectal cancer: after passing through the phase of flat dysplasia and hyperplastic lesions, the 
inflamed mucosa evolves to carcinoma [127, 128]. In addition to genomic instability that 
sustains the process of tumorigenesis, the presence of a chronic inflammation, characterized by 
high levels of cytokines, chemokines, growth factors and reactive oxygen species, seems to be 
a key factor in sustaining and promoting CRC. During colorectal carcinogenesis, epithelial cells 
accumulate genetic mutations and release several inflammatory mediators that act on 
leukocytes, endothelial cells and fibroblasts, promoting the establishment of a reactive tumor 
microenvironment. In particular, IL-6 plays a crucial role in CRC carcinogenesis being a key 
component in the transition from acute to chronic inflammation [129]. IL-6 is mainly produced 
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by myeloid cells and once secreted it binds its receptor IL-6R leading to the dimerization of 
gp130 expressed by tumor cells; this event activates JAK that in turn phosphorylates STAT3, 
inducing the expression of crucial genes in cell cycle progression and suppression of apoptosis. 
Indeed, STAT3 modulates chemokine and adhesion molecule expression, supporting intestinal 
cell proliferation: recent studies showed that serum levels of IL-6 in colorectal cancer patients 
are higher than in healthy controls and correlate with a poorer survival rate [130].  On the 
contrary, IL-10 is a key molecule in inflammatory resolution and is downregulated during 
carcinogenesis development. It has been demonstrated that knock out mice for IL-10 
spontaneously develop colitis while they are protected from colon cancer occurrence after 
exogenous administration of IL-10 [131]. Conversely, TGF-β modulates epithelial cell 
differentiation and inhibits cell growth. Studies have established that the TGF-β signaling 
pathway is mutated in CRC. In this context, TGF-β can inhibit T CD8+ lymphocytes limiting 
their beneficial effects on patient outcomes and promoting tumor growth and progression 
[132]. Finally, TNFα is another important cytokine involved in CRC pathogenesis. Several 
lines of evidence suggest that TNFα has a key role in IBD occurrence and promotes neoplastic 
cell growth, invasion and metastasis. Recent studies showed that mice lacking the type 1 
TNFR-p55 are protected from the development of colorectal cancer in a model of 
inflammation-associated carcinogenesis [133].  
 
Fig.14: Inflammation can trigger cancer [134] 
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In CRCs, tumor-infiltrating cells predominantly include TAMs, myeloid derived 
suppressor cells (MDSCs), mesenchymal stem cells (MSCs), CD4+ T lymphocytes, CD8 + T 
lymphocytes, regulatory T cells (Tregs), mast cells, platelets, cancer-associated fibroblast 
(CAFs), endothelial progenitor cells, monocytes and neutrophils. All these cells synergically 
interact with the extracellular matrix and matrix-associated molecules such as collagen, 
laminin, integtrins, MMPs, mucins and hyaluronic acid to modulate CRC progression. CAFs, 
are the main cellular constituents of the reactive stroma in primary and metastatic cancer and 
have a crucial role in CRC development: they facilitate tumor growth by secreting growth 
factors, are involved in the production of ECM and matrix-associated molecules and promote 
tumor-related angiogenesis, invasion and metastasis. Also mast cells and neutrophils play a role 
in CRC angiogenesis. Recent studies revealed that in CRC patients a lower number of mast 
cells was associated with hypovascularity and better survival rate [86, 135]; moreover, 
neutrophil-derived MMP-9 releases biologically active VEGF from the ECM by the cleavage of 
heparan sulfates [136]. Indeed, the expression levels of some MMPs is elevated in human CRC 
and correlates with stage of disease and/or prognosis: for example, MMP3 in CRC is associated 
with low levels of microsatellite instability and poor prognosis, whereas overexpression of 
MMP12 is related to increased survival [137]. Several studies confirmed that high levels of 
tumor infiltrating lymphocytes (TILs), in particular located intraepithelially, are associated 
with favourable prognosis in colorectal cancer. Galon and colleagues identified a dominant 
cluster of genes involved in Th1 immune responses that inversely correlates with tumor 
recurrence; moreover, they demonstrated that adaptive immunity promotes patient survival, 
prevents tumor recurrence and can have a beneficial effect during tumor progression [138]. In 
addition, Pages et al. found increased levels of mRNA of markers of Th1 effector T cells that 
positively correlate with prolonged survival and the absence of pathological signs of early 
metastatic invasion [139]. Finally, Laghi recently demonstrated the CD3+ T cell levels at the 
invasive margin of early tumors are associated with a lower risk of metachronous metastasis 
and a survival advantage [140].  
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Tumor associated macrophages in colorectal cancer 
 
Considering their pro-tumoral functions, in the majority of cases, TAM infiltration 
correlates with tumor progression and consequently worst patient prognosis. Indeed, high 
density of TAM has been significantly associated with poor prognosis in the majority of tumors. 
In colorectal cancer, the role of TAM is still controversial. To define TAM function, their 
localization appears of primary importance [121]. Despite some reports describe TAM to have 
an anti-tumoral function, in many studies there is evidence that TAMs exert a pro-tumoral 
activity in CRC promoting tumor growth and metastasis by inducing angiogenesis, ECM 
breakdown and enhancing tumor cell migration/invasion. A massive macrophage infilitration 
is correlated with tumor progression, growth and disease aggressiveness. The process of tumor 
invasion and metastasis is supported by the release of CSF-1 by neoplastic cells. CSF-1R is 
expressed by macrophages and the axis is able to recruits TAM that contribute to the epithelial-
to-mesenchymal transition (EMT), an initial event for cancer metastasis [86, 141]. Beside this, 
both TAMs and colon cancer cells secrete TGFβ that leads to EMT by activating the Smad 
pathway. In addition, stromal cells of the microenvironment, stimulate macrophages to secrete 
cathepsins, MMPs  (MMP2 and MMP9) and serine proteases that cleave cell adhesion  
molecules, such as E-cadherin  and the ECM and favor tumor spread. A further evidence of the 
putative pro-tumoral role of TAM in CRC was provided by Kaler and colleagues: their study 
reported that TAM, through IL-1β, stimulate the Wnt-β catenin signalling patwhay in colon 
cancer cells supporting tumor growth. Pancione et al. also reported that reduction or loss of  
β-catenin and peroxisome proliferator-activated receptor-γ (PPAR- γ) expression correlated 
with high COX-2 levels, massive TAM infilitration and tumor aggressiveness [142]. Another 
important pro-tumoral activity of TAM is the production of IL-23, a crucial cytokine for the 
polarization of Th17 lymphocytes. Recently, in some tumors, including CRC, high levels of 
IL-23 has been detected; this cytokine promotes tumor growth by stimulating inflammatory 
responses, up-regulation of MMP9, increased angiogenesis and reduced CD8+ cell infiltration. 
On the contrary, some studies highlight the beneficial role of TAM in CRC. For instance, 
Sugita and colleagues demonstrated the correlation between the number of macrophages at the 
tumor margin and the number of apoptotic cancer cells, suggesting a Fas ligand dependend 
apoptosis induced by macrophages [121]. Moreover, Funada et al. showed that high levels of 
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macrophages at the invasive front are linked with an increased overall survival rate; while 
Khorana et al. analysed the presence of VEGF-expressing TAM and found significant 
correlation with favorable outcome [143, 144].  Finally, Forssell et al. showed that the 
interaction between TAM and tumor cells is necessary to activate the anti-tumorigenic 
immunity and that, consequently, the macrophage infiltration at the tumor front positively 
influenced colon cancer prognosis [145].  
Overall, these data highlight the controversial role of TAM in CRC suggesting that their 
pro- and anti-tumor effects may depend on their localization within cancer tissue. At the 
invasive margin, macrophages are located in less hypoxic areas and seem to have less exposure 
to tumor-derived cytokines: this condition may trigger macrophage tumoricidal differentiation 
instead of promoting their pro-tumoral phenotype. On the contrary, the high level of hypoxia 
in the stroma can trigger macrophages to be in syntony with the tumoral microenvironment 
and, consequently, to acquire a pro-tumoral phenotype. Reasonably, macrophages may also 
have different effects at different stages of tumor progression. At early stages, they cooperate 
with other innate immune cells and eliminate tumor cells by activating adaptive responses, 
while at advanced stages TAM shift toward M2-polarized cells and support tumor progression. 
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Mouse Models 
 
In spite of a well-established evidence that chronic inflammatory conditions promote 
cancer development, the underlline molecular mechanisms are not fully elucidated. Mouse 
models of disease have been used and represent an useful and appropriate methodology to 
investigate human diseases, including colorectal cancer and it relationship with inflammation. 
There are many methods to induce inflammation in colon and different genetically engineered 
mice to investigate different aspects of this complex pathology. Indeed, using mice instead of 
in vitro methods provides the opportunity to study interrelated processes from both a 
pathological and a physiological point of view: to investigate the dynamic tumor 
microenvironment and the complex network between stromal components, inflammatory 
cells and neoplastic cells, the use of a whole-body system provides more valid and detailed 
information. Mice can spontaneously develop cancer or be susceptible to chemical induction 
of carcinoma. A number of genetically engineered animals, where the expression of one or 
more genes is selectively suppressed (knock-out, KO mice) are available. Many events can 
trigger colon cancer such as mutations in the germinal lines, sporadic mutations or toxic agents 
that can cause inflammation or alter the DNA integrity. In this complex scenario, KO mice are 
a useful model to investigate the different pathways that can lead to cancer development (table 
2). For instance, IL-10 is a key regulator of the pathogenesis of IBD and the hystopathology of 
chronic colitis in IL-10 KO mice is very similar to that seen in IBD patients: epithelial 
hyperplasia, inflammatory infiltrates in the mucosa and crypts abscesses have been detected 
both in IL-10-/- mice and UC and Chron's disease patients [146]. It has to be considered, 
however, that IL-10-/- mice do not show the same involvement of genes that characterize 
human carcinogenesis such as APC, RAS and p53, nevertheless these animals mirror what 
happens in the intestine of IBD patients by spontaneously developing colitis and CAC. Another 
relevant model largely used is the APCmin. The mutation of the APC gene is an early causative 
event in familial and sporadic colon cancer pathogenesis, for this reason APCmin mice have been 
long used to study CRC. The APCmin mouse model is generated by a mutation in the tumor 
suppressor gene APC; APC mice, homozygous for the mutation, are not vital and show 
embryonic lethality, while heterozygous mice survive until 120 days [131]. The APC gene 
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mutation leads to mitotic defects in histologically normal crypt cells of the murine small 
intestine and provides changes in crypt dimensions, cell proliferation and apoptosis.  
Consequently, the formation of microadenomas that result from DNA hypomethilation occurs 
(figure 15). 
 
 
 
Fig.15: The APC gene is composed by 2843 aminoacids. The great number of mutations that occur 
in CRC are in the MCR region [147].  
 
As for IL-10-/- mice, also this model shows some differences with human in the 
progression of the disease. For instance, APCmin mice spontaneously develop polyps 
predominantly in the small intestine, while in humans polyps and CRC develop mostly in the 
colon [131]. This is the reason why APCmin mice are often treated with chemical agents to 
promote polyps development also in the colon.  
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Tab.2: Different mouse models used in CRC and CAC investigation [131]. 
 
 
Another approach to investigate the link between inflammation and CRC is to induce 
carcinogenesis with chemical agents (table 3). Reagents can be used in combinations or in 
association with genetically engineered models in order to mimic the different etiology linked 
to colorectal carcinoma development. The most common used model to study CAC is the 
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association between a carcinogen and a substance able to irritate the mucosa and, consequently, 
to promote inflammation. Indeed the most and frequently model used by researchers is a 
combination of azoxymethane (AOM), a carcinogen widely used to enhance the formation of 
colorectal tumors in rodents and the administration of Dextran Sodium Sulfate-induced (DSS) 
(tab). DSS can be used in combination with AOM -or other carcinogens- or alone. In both 
cases, the administration of DSS can cause a disease that quite faithfully reproduces the clinical 
course of UC. Because in humans the spontaneous onset of active inflammation is separated by 
periods of disease inactivity, DSS is usually administrate for 3-7 days in mice followed by 
regular water administration for 1-2 weeks to trigger colonic mucosa healing [131].  
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Tab.3: Different combinations of chemical agents use to promote colon cancer. Protocols change 
based on the duration of the experiments, the way of administration and the mouse background [131]. 
 
It has been established that due to the synergic effects of AOM (a tumor-inducing agent) 
and DSS (a tumor-promoting agent) the AOM/DSS model mirrors colorectal carcinogenesis 
[148].  
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Importantly, the AOM-DSS-induced tumors share very similar features to human CRC 
even at molecular level: as in human CRC, tumors display evidence of dysregulation of the 
APC/β-catenin-signaling pathway due to the mutation in the β-catenin coding gene induced 
by AOM. This event aberrantly activates Wnt signaling pathway and leads to β-catenin 
cytoplasmatic and nuclear accumulation. Moreover, mutations of K-Ras and increased levels 
of enzymes involved in prostaglandin and nitric oxide synthesis such as COX-2 and iNOS can 
occur [149]. According to its particular ability in reproducing many aspects of human CRC, 
the AOM/DSS model is a feasible protocol that can also efficiently reproduce the multistep 
tumor development from microadenomas to adenocarcinomas passing through the phase of 
macroscopic adenomas and adenomatous polyps. For example, Tanaka and colleagues showed 
that already after 3-4 weeks from the beginning of the AOM/DSS protocol, luminal colon 
mucosa displays aberrant crypts infiltrated by a high number of inflammatory cells (including 
lymphocytes and plasma cells) and nascent tumors . These events have been observed also in 
humans were colitis-associated cancer is characterized by a dense infiltrate of immune cells 
(macrophages, DCs and T cells).
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AIM of the thesis 
 
The intestinal mucosa is a very peculiar environment from the immunological point of view as 
it is continuously exposed to foreign antigenic material and to the many commensal microbes that 
colonize the gut. The intestinal immune system has the difficult task of discriminating between 
harmless antigens and harmful pathogens, and generating tolerance or protective immunity, 
appropriately. Indeed, the balance between tolerance and immune response is very delicate and tightly 
regulated. Among the cells and soluble mediators that regulate gut homeostasis are resident intestinal 
CX3CR1+ macrophages, T regulatory cells and the anti-inflammatory cytokines IL-10 and TGF.   
Gut resident CX3CR1+ macrophages play a crucial role in the maintenance of intestinal 
homeostasis by the production of IL-10 and the ability to sense this cytokine in an autocrine loop. These 
macrophages are characterized by the expression of the chemokine receptor CX3CR1; however, how 
this receptor is involved in the molecular mechanisms that regulate the inflammatory response, is 
largely unknown. Furthermore, while the function of intestinal CX3CR1+ macrophages in acute 
inflammation has been described, their role in the resolution phase and in chronic inflammation has 
not been investigated. Intestinal chronic inflammation is a state predisposing to colorectal 
carcinogenesis; indeed, it is now established that cancer-associated inflammation promotes cancer 
progression in all its phases: from the early events till the spread of the metastasis. It is therefore 
important to understand if and how these “regulators” of gut inflammation are involved in the process 
of colorectal carcinogenesis. 
The global aim of this thesis is to define the role of mucosal CX3CR1+ 
macrophages during the process of intestinal carcinogenesis, and to dissect the 
molecular mechanisms by which these immune cells maintain gut homeostasis. 
By using genetically modified mice for the chemokine receptor CX3CR1, we have analyzed 
animals deficient (CX3CR1GFP/GFP) or proficient (CX3CR1GFP/+) for this signaling pathway. Mouse 
models of chemically-induced acute and chronic inflammation, as well as of colitis-induced cancer have 
been performed to specifically achieve the following goals:   
- Characterize the state of colonic inflammation upon acute tissue injury and during the process of 
recovery  
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- Understand the role of mucosal CX3CR1+ macrophages in steady state and in the inflammatory 
response and recovery 
- Understand the role of mucosal CX3CR1+ macrophages in the process of chronic colitis leading to 
colorectal carcinogenesis  
- Characterize the molecular mechanisms underlying the anti-inflammatory function of CX3CR1+ 
macrophages with a special focus on CX3CR1 signaling 
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Materials & Methods 
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Mouse models  
Procedures involving animals and their care conformed to institutional guidelines in 
compliance with national (4D.L. N.116, G.U., suppl. 40, 18-2-1992) and international law 
and policies (EEC Council Directive 2010/63/EU, OJ L 276/33, 22.09.2010; NIH Guide for 
the Care and Use of Laboratory Animals, U.S. National Research Council, 2011). All efforts 
were made to minimize the number of animals used and their suffering. 
All mice used were of the C57BL/6 background. We compared CX3CR1+/GFP (WT) 
to CX3CR1GFP/GFP (KO) and CX3CR1+/GFP-APCmin (WT) to CX3CR1GFP/GFP-APCmin (KO). 
Mice were maintained in a specific-pathogen free facility 
 
DSS-induced colitis 
C57BL/6 CX3CR1 WT and KO mice were used to generate a model of colitis. Six- to 
eight-week-old male mice with an initial weight of 18-20 g received 3% of dextran sulfate 
sodium (DSS-MP biomedical) dissolved in drinking water for 7 days. Mice were sacrificed at 
day 7. In order to assess the recovery of colitis, some mice were fed with normal water after 
day 7 and sacrificed at day 10 or 13. During the experiment, twice a week, weight loss was 
measured evaluate the level of colitis 
 
Models of colitis-associated cancer 
AOM-DSS model of colitis-associated cancer 
C57BL/6 CX3CR1 WT and KO mice were used to generate a model of colitis-
associated cancer (CAC).  
Six- to eight-week-old male mice with an initial weight of 18-20 g received a single 
intraperitoneal (i.p.) injection of azoxymethane (AOM-from SIGMA-; 10 mg/kg of body 
weight). Water containing 3% DSS was administered to mice beginning on day 7 for 6 days, 
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followed by 15 days of fresh water. The treatment was repeated twice for a total of 3 rounds 
of DSS. Mice were euthanized on day 70 after the 10-week treatment (figure 16). 
 
 
Fig 16.: AOM-DSS protocol 
 
During the experiment, mouse weight loss and stools blood and consistency were 
monitored twice a week to provide an assessment of cancer-associated colitis and cancer 
severity during the treatment. Hemoccult test from SENSA was used to detect occult blood 
and to evaluate stools consistency (table 4). 
 
Weight loss Score Stool blood Score Stool consistency Score 
< 1% 0 Negative 0 Normal 0 
1-5% 1 Positive to Hemoccult 1 Soft 1 
5-10% 2 Visible blood 2 Very soft 2 
10-15% 3 Gross bleeding 3 Diarrhea 3 
> 15% 4     
 
Tab 4: Disease Activity Index (D.A.I.). Every week stool blood and consistency were 
analyzed in respect to values reported in the table.  
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Induction of hemox-1 during the AOM-DSS model 
Cobalt protoporphyrin IX (coPP) was prepared in dim light because of the 
photosensibility of the compound. It was dissolved in sodium hydroxide (NaOH) 150mM and 
then the pH was adjusted to pH 7 by adding equal amount of hydrochloric acid (HCl) at the 
final concentration of 5mg/ml. The final pH of 7,4 was achieved by further dilution with 
Phoshate Buffer Saline without Calcium and Magnesium (PBS-/-, BioSera). 300ug of coPP or 
vehicle (NaOH and HCl) in a final volume of 200ul was given to mice following the scheme 
reported in figure 17:  
 
 
Fig. 17: The AOM-DSS protocol implemented with coPP administration 
 
APCmin model of colitis-associated cancer 
CX3CR1+/GFP-APCmin (WT) and CX3CR1GFP/GFP-APCmin (KO) mice were used to 
generate a genetic model of colitis-associated cancer. Four-week-old male mice with an initial 
weight of 17-19 g received 2,5% DSS in drinking water until day 7. Subsequently, mice were 
fed with fresh water for four weeks and then euthanized on day 35 after 5-week treatment. 
 
Histological analysis 
After mouse sacrifice, colons were isolated and excised for histological analysis and 
immunofluorescence. 
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Colons were harvested, flushed of luminal contents, and opened with a longitudinal 
cut; next, they were rolled up transversely (swiss roll), with the distal region inside the swiss roll.  
Tissues were then fixed in 4% paraformaldehyde (PFA) overnight at 4°C and 
dehydrated first in 30% sucrose in PBS−/−, for 6 hours and then in 40% sucrose in PBS−/−, 
overnight. Next, the colonic tissues were embedded in OCT (optimum cutting temperature 
compound, Diapath) and stored at -80°C.  
To evaluate the histological architecture of the inflamed colon and calculate the 
percentage of the adenomatous area over the total tissue, 8 µm thick frozen sections were cut 
with cryostat, placed on a glass slide and stained with hematoxylin and eosin (H&E stain). 
Sections were fixed with 4% formalin for 5 minutes, washed in tap water for 5 minute, 
stained with hematoxylin (3 minutes), quick washed and stained for 2 minute with eosin. The 
eosin excess was then removed by quick washes in water and sections dehydrated with 
increasing concentration of EtOH (from 70%-100% EtOH). Finally the slides were cleared 
with xylenes and mounted with a xylenes-based mounting medium. Slides were observed with 
microscope (4x) and colitis score was assessed as in the following table (5):  
Score Description  
0 Normal mucosa 
1 First signs of inflammation: few inflammatory cells, crypts well defined and equidistant. 
2 
Many inflammatory cells in the mucosa. Crypts are destroyed or irregular and no more 
equidistant. Presence of open or repaired ulcers. 
3 
The tissue architecture is lost. Leukocytes invade the muscolaris mucosae. Crypts are totally 
destroyed and the tissue is full of open ulcers. 
Tab 5: Histological damage evaluation (colitis score) 
In order to define polyps’ growth, slides were scanned with VS120 Dotslide (Olympus) and 
analysed with OLYVIA software. 
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Immunofluorescence 
For immunofluorescence staining, frozen tissue sections (8 µm) were firstly rehydrated 
with pH 7 Phosphate Buffer Saline with Calcium and Magnesium (PBS+/+- BioSera). Sections 
were then fixed in 4% PFA for 15 minutes.  
Subsequently, tissues were permeabilized and blocked with 0.1% Triton X-100 (Sigma 
Aldrich), 2% Bovine Serum Albumin (BSA), and 5% Normal Goat Serum in PBS+/+ for 30 
minutes in a dark incubation chamber. Section were washed for 5 minutes in PBS+/+ Tween-
20 0,05% (washing buffer) and subsequently incubated with the primary antibody(ies) in 
washing buffer (1 hr at room temperature or 4°C overnight, depending on antibody).  
After three washes in washing buffer, sections were incubated with fluorophore-coniugated 
secondary antibody(ies) at room temperature for 1 hr in the dark (1:2000). 
Finally, sections were washed four times, cell nuclei counter-stained with DAPI, 
washed out the excess of DAPI with water and mounted with a fluorescence preserving 
medium (Fluorsave, Calbiochem). Slides were then kept protected from light at room 
temperature. Negative controls were generated by omitting the primary antibody(ies). 
Images were captured with the Olympus FluoViewTM FV1000 confocal microscope. 
The acquired images were analysed with “(Fiji is just) ImageJ software”. Multi-channel images 
were split to the respective components and every channel was transformed into a binary 
image. According to the “set measure” option, the percentage of stained tissue in each 
component was calculated overall the total black background of the single slide. Considering 
the DAPI stained tissue as the entire tissue (100%), we finally calculated the percentage of 
tissue stained by every single fluorophore using the mathematical proportion: 
    %DAPI:100 = %fluorophore: X 
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Whole mount 
After mice sacrifice, animals were perfused with 2% PFA injected directly in the heart 
and colons excised, flushed from luminal contents and fat. Tissue were subsequently stretched 
and attached with fine pins to a small silicone rubber slab. Colons were fixed by immersion in 
4% PFA overnight at 4°C; fixative was washed out with several changes of PBS+/+. Samples 
were incubated overnight at 4°C with primary antibodies diluted in the following staining 
buffer: PBS+/+, BSA 2%, Normal Goat Serum 5%, Triton X-100 0,1%, Sodium Azide 0,01% 
(NaN3-Merck). After incubation, tissues were washed several times in PBS-/- - Tween-20 
0,05% for 15 minutes each time (5 hours in total) and then incubated overnight at 4°C with 
secondary antibodies diluited in PBS+/+, Tween 20 0,05%, Triton X-100 0,1%, NaN3 0,01%. 
Finally, washing steps were repeated and tissues were mounted with Vectashield (Vector 
Laboratories). Slides were stored at 4°C. 
 
Stack acquisition and morphometric analysis with Imaris software 
Whole mount specimens were examined from serosa to mucosal crypts with the 
Olympus FluoViewTM FV1000 confocal microscope. Confocal images were obtained scanning 
samples at a 40-150 µm depth collecting sequential XY images every 1 µm. Stacks were 
imported and processed using IMARIS software.  
 
Antibodies 
The following antibodies were used. 
Primary antibodies: Rat anti-mouse F4/80 monoclonal antibody (eBioscience) 1:500, 
Armenian Hamster anti-mouse CD31 monoclonal antibody (Millipore) 1:500, Hamster anti-
mouse CD103 monoclonal antibody (LsBio) 
Secondary antibodies: Goat anti-rat IgG cross adsorbed Alexa Fluor® 594-conjugated 
(Invitrogen Molecular Probes) 1:2000, Goat anti-rabbit IgG cross adsorbed Alexa Fluor® 594-
conjugated (Invitrogen Molecular Probes) 1:2000, Goat anti-rat IgG cross adsorbed Alexa 
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Fluor® 647-conjugated (Invitrogen Molecular Probes) 1:2000, Goat anti-armenian hamster 
IgG cross adsorbed Alexa Fluor® 647-conjugated (Invitrogen Molecular Probes) 1:2000. 
 
RNA extraction and quantitative Real-Time PCR 
Total RNA was extracted from colon tissue previously washed from luminal content 
and fragmented into small pieces (approximately 1 mm) or from cell culture. 
In the CAC experiments, polyps were separated from the rest of the colon and analysed 
independently.  
Samples were homogenized in TRIZOL (Ambion) using Tissue Lyser II (Quiagen). 
Homogenized tissues were then added with chloroform in order to separate RNA from 
genomic DNA and proteins. RNA isolation and purification required isopropanol (RNA 
precipitation) and 70% ethanol (RNA wash). Total RNA was resuspended in Nuclease-free 
water and quantified using the spectrophotometer NANODROP ND-1000. Subsequently, 1 
μg of RNA was reverse-transcribed using the High Capacity cDNA Reverse Transcription Kit 
(Applied Biosystems) following manufacturer’s instructions. cDNA analysed through 
quantitative Real-Time PCR, performed on Viia-7 instrument (Thermo Fisher Scientific) using 
the Fast SYBR Green system. The thermal-cycling conditions for the Fast SYBR Green Master 
Mix are described in the table 6. 
Cycling step Temperature Hold time # of cycles 
Initial denaturation and enzyme activation 95 °C 2:00 1 
Denaturing 95 °C 0:10 
40 
Annealing and extension 60 °C 2:00 
Melt curve 65-95° C 
(in 0,5 °C increments) 
0:5 1 
 
Tab 6: The Fast SYBR Green cycling-protocol. 
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GAPDH gene was amplified as internal control. The others genes analysed are the follow: 
GAPDH 
Fw-GGCATTGCTCTCAATGACAA 
Rev-ATGTAGGCCATGAGGTCCAC 
IL-6 
Fw-CCGGAGAGGAGACTTCACAG 
Rev-CAGAATTGCCATTGCACAAC 
IL-23 
Fw-GACCCACAAGGACTCAAGGA 
Rev-AGGCTCCCCTTTGAAGATGT 
IFNγ 
Fw-ACTGGCAAAAGGATGGTGAC 
Rev- GCTGATGGCCTGATTGTCTT 
HEMOX-1 
Fw-CAGGTGATGCTGACAGAGGA 
Rev-TCTCTGCAGGGGCAGTATCT 
TNFα 
Fw-CCACCACGCTCTTCTGTCTA 
Rev-AGGGTCTGGGCCATAGAACT 
IL-10R 
Fw-CACATCCTCCACTGGAAACC 
Rev-TGGATGTCATTCCAGGTTGA  
IL-10 
Fw-AGCCGGGAAGACAATAACTG 
Rev-ATGTTGTCCAGCTGGTCCTT 
IL-19 
Fw-ATCCTGTCCCTGGAGAACCT 
Rev-TCCTGGAACACCCTGTCTCT 
TGFβ 
Fw-TGGAGCAACATGTGGAACTC 
Rev-AGACAGCCACTCAGGCGTAT 
IL-20 
Fw-CATTGTGGGGAAGAAGCAAT 
Rev-TTCTCCCAAAGCCTTTACCA  
MMP-9 
Fw-ATAGGCTTTGTCTTGGTACTG 
Rev-AGGAGTCTGGATAAGTTGGG 
IL-22 
Fw-CCGAGGAGTCAGTGCTAAGG 
Rev-CATGTAGGGCTGGAACCTGT 
IL-12 
Fw- CTCCTGTGGGAGAAGCAGAC 
Rev- CAGATAGCCCATCACCCTGT 
COX-2 
Fw-CCCCCACAGTCAAAGACACT 
Rev-GGCACCAGACCAAAGACTTC 
IL-1β 
Fw- GAGTGTGGATCCCAAGCAAT 
Rev-TACCAGTTGGGGAACTCTGC 
iNOS 
Fw-GCACGATGTCATATTCCTTCCTCC 
Rev-TTTGAGTAGCCTGATCC 
 
 
Quantification of the PCR signals of each sample was performed by comparing the cycle 
threshold values (Ct), in duplicate, of the gene of interest with the Ct values of the GAPDH 
housekeeping gene.  
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Western blot 
The presence of Hemo-oxygenase-1 was tested in both inflamed colon and polyps 
through Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) and 
western blotting assay. Samples were harvested after mice sacrifice and protein extracted using 
Urea buffer (Urea 9M, 25mM Tris-HCl pH 6,8, 1mM EDTA, 10% glycerol). 25ng of total 
proteins were resolved on 10% SDS-PAGE and transferred onto Trans Blot Transfer Medium, 
Nitrocellulosa membrane (Bio-Rad). Filters were blocked with with 5% milk in TBST (50 mM 
Tris, 150 mM NaCl and 0.05% Tween 20) and incubated over-night with affinity-purified 
rabbit anti-mouse Heme-oxygenase-1 antibody (proteintech) 1:600. After the incubation with 
peroxidise-conjugated donkey anti-rabbit IgG (Biosciences), the membrane were developed 
with chemiluminescence reagent (Bio-Rad), according to the manufacturer's instructions, and 
visualized with Chemidoc System (Bio-Rad). 
 
Generation of bone marrow derived macrophages (BMDMs) 
Bone marrow was harvested from femura of 8- to 12-week old mice by flushing the 
marrow out with IMDM supplemented with 10% Fetal Calf Serum (FCS) and ACK 
(100uL/bone) to lysate red cells. Flushed cells were resuspended in 20 mL IMDM, 10% FCS, 
1% Penicillin/Streptavidin, 1% Glutammine and let to adhere overnight at 37°C, 5% CO2. 
After incubation, cell supernatant was removed, non-adherent cells were spun down and 
resuspended at the concentration of 0.5x106 cells/mL in complete bone marrow macrophage 
medium (IMDM, 10% FCS, 20 ng/mL M-CSF) in suspension culture dish (Corning) 
(10mL/dish). After 7 days, cells are lifted and replated for stimulations and analyses. 
Cells were plated at the final concentration of 2.5x105 cells/mL in 24 wells plate and 
stimulated with LPS (100ng/mL), recombinant Fractalkine (FKN, 300ng/mL) or LPS-FKN. 
To simulate acute inflammation, cells were stimulated for 18h with fractalkine and then 4h 
with LPS, while to simulate the recovery process, cell were stimulated with LPS for 4h and 
then with FKN for 18h. Subsequently, cells and supernatants were harvested for analyses. 
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Supernatants were centrifuged to remove cellular debris and analysed with ELISA kit 
for IL-6, TNF-α, and IL-10 (R&D Systems). Cells were lysate to recover RNA as already 
described, and used for qPCR analysis. 
 
Isolation of mononuclear cells from lamina propria 
To isolate lamina propria mononuclear cells (LPMCs), extraintestinal fat tissue was 
carefully removed and colons were then flushed of their luminal content with physiologic 
solution, opened longitudinally and cut into 1 cm pieces. Epithelial cells and mucus were 
removed by 40 min incubation with HBSS (without Ca2+ and Mg2+) containing 5% FBS, 2 
mM EDTA at 37°C, shaking at 275 rpm. Colon pieces were then digested in HBSS-/- 
containing 5% FBS, 0,5 mg/ml Collagenase VIII (Sigma), for 40 min at 37°C shaking at 275 
rpm. The obtained cell suspension was then pressed into a syringe needle, washed with RPMI 
and passed sequentially through 100 and 40 µm cell strainers. Cells were centrifuged for 6min 
at 1600 rpm, resuspended in RPMI and used for the subsequent analysis.  
 
Phagocytosis Assay 
In order to determine the ability of CXRCR1+ MO to phagocyte, peritoneal-elicited 
macrophages were harvested from WT and KO mice. Briefly, 1ml of thioglycolate (3% 
thioglycolate medium w/o dextrose, BD; Franklin Lakes, NJ) was injected intra-peritoneum 
(IP). After three days, mice were sacrificed and 10 ml of cold physiologic solution were 
injected in the peritoneum, cells were collected and kept in ice. Live cells were sorted using 
FACS Aria instrument based on GFP gene reporter expression. After, 2x105 cells were plate 
on glass slides in 24 wells in DMEM overnight. In the meantime, polystyrene latex beads 
(Sigma-Aldrich), 3 μm in diameter were coated with LPS diluted 1:100 in bicarbonate buffer 
in a ratio of 1:10 cells/beads by incubating for 1h at 37°C shaking. Beads were washed one 
time with HBSS-/- and added to cells for 1h. The excess of beads was washed out and cells 
stained and fixed with DiffQuik (medion diagnostics) and mounted on glass. Beads were 
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counted at the microscope, analysing ten fields for each samples. The percentage of 
phagocytosis was calculated as follow:  
 
n cells: n bead =100: x 
Flow cytometry  
Flow cytometry analyses were performed to determine the percentage of immune cells 
infiltrate. Briefly, cells were harvested from colon samples of both polyps, inflamed colon and 
healthy control as described before. 5x105 cells per tube were washed with FACS buffer (PBS 
-/-, 2% FBS), and incubated 30 min at 4°C with antibodies. Subsequently, cells were washed 
twice with 1 mL of FACS buffer and suspended in 350ul of FACS buffer. Immediately, cells 
were read using FACS Canto II instrument and FACS Diva software version 6.1.1 (BD 
Biosciences). For each experiment, cells were stained with appropriate isotype control 
antibodies to establish background staining before calculating the percentage of positive cells. 
Antibodies used for colonic lamina propria staining included: CD45 percP (BD), 
CD11b pacific blue (eBiolegend), F4/80 PE (Serotec), Ly6G PE-cy7 (BD), Ly6C APC (BD), 
TLR2 APC (BD). 
Phospho-protein detection  
To detect the expression of phosphorylated protein, spleen was collected from mice, 
smashed in DMEM and treated with ACK to lysate blood red cells. 2x106 cells were suspended 
in DMEM at 37°C and stimuli were added (IL-10 25ng/mL, FKN 300ng/mL) to a final volume 
of 300ul. Cells were treated for 5’, 30’ or for 120’. After the treatment, 50 ul of PFA 16% 
were added for 10’ at room temperature, to block the incubation and fix the cells. After two 
centrifugations, cold methanol was added for 20’ to permeabilize cells. Methanol was removed 
with three washes in PBS-/- and samples were stained with pSTAT3 (py705-BD) for 30’ at 
room temperature in the dark. After the incubation, cells were washed and suspended in 350ul 
of FACS buffer (PBS-/-, FBS 1%, NaN3 0,1%) and analysed with CANTO II instrument. 
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Statistical Analysis 
Statistical analysis was performed with GraphPad Prism 6 (GraphPad Software). To 
compare different data sets, unpaired two-tailed Student’s t test was used and results were 
expressed as mean ± SEM or median and quartiles. 
A value of p<0.05 (*) was considered as statistically significant (** p<0,01;*** 
p<0,001; p<0,0001****).  
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Results 
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Comparison of wild type mice and heterozygous CX3CR1GFP/+ 
mice 
The CX3CR1 gene was reported to be fully functional in heterozygous mice. 
Nevertheless, we decided to compare WT and CX3CR1GFP/+ mice in order to establish if there 
were any differences between the two strains. Considering that our major interest was the 
understanding of the role of CX3CR1+ macrophages in the development of colorectal cancer, 
we performed our experiments using a model of colitis-associated cancer. Three physical 
parameters were used to establish the level of inflammation and the development of neoplasia: 
colon length, colitis score and the percentage of adenomatous tissue out of the total colon. As 
shown in figure 18, there were no differences between WT and CX3CR1GFP/+ mice, while the 
variances between KO and WT or heterozygous mice were of the same extent. Based on the 
finding that the other allele remains functional, we adopted CX3CR1GFP/+ mice, instead of 
using WT, because of the presence of the GFP gene. In this way, we were able to track 
CX3CR1+ macrophages in both strains. Therefore, in this thesis, CX3CR1GFP/+ mice are 
referred as WT mice. 
 
Fig.18: Comparison of WT and CX3CR1GFP/+ mice: colon length, colitis score and the percentage 
of adenomatous tissue are three parameters used in the evaluation of tissue damage in mice treated 
with the AOM-DSS model. Here we compared WT and heterozygous mice and we found that they 
displayed the same behavior which is significantly different from that of KO mice.  
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Characterization of CX3CR1+ cells 
 
 
Fig. 19 Characterization of CX3CR1+ macrophages 
Phenotype of resident macrophages in healthy colon by FACS analysis: (A) CX3CR1+ cells are a sub-
population of macrophages in the colon expressing F4/80 and CD11b. Moreover, this subset express 
the marker CD64 (B). (C) Whole mount of healthy colonic tissue, magnification 20X. CX3CR1+ 
(green) cells co-localize with F4/80+ (red) macrophages and many spots of colocalization (yellow) are 
visible (I). CX3CR1+ (green) cells do not co-localize with dendritic cells positive for CD103 (red)(II). 
 
Since now, the characterization of CX3CR1+ cells in the lamina propria gave 
controversial results. Indeed, when these cells were first characterized, they were considered 
dendritic cells. Nowadays, it is widely accepted that these cells are macrophages. We first 
wanted to confirm that CX3CR1+ cells are resident macrophages that colonize the gut 
mucosa. To do this, we harvested cells from healthy colon of both CXRCR1GFP/+ and 
CX3CR1GFP/GFP mice and we performed FACS analysis. We first demonstrated that CX3CR1+ 
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cells represent 6% of all CD45+ leukocytes. Among these, 80% are macrophages positive for 
F4/80 and CD11b. Next, we found that CX3CR1+ cells are a particular subpopulation of 
macrophages expressing also CD64 as it was reported by Mowat and colleagues [150]. In fact, 
considering the percentage of positive macrophages expressing CX3CR1, we were able to 
demonstrate that 70% of these cells express also CD64. Interestingly, no differences between 
WT and KO were observed (figure 19).  
In order to completely exclude that CX3CR1+ cells are dendritic cells, we performed 
immunofluorescence analysis on whole healthy colon. We performed a double staining for 
F4/80, a macrophage marker, and for CD103, a dendritic cell marker. As shown in figure 19, 
panel C, many F4/80+ cells are also CX3CR1+ confirming, by mean of a different technique, 
that CX3CR1+ cells are indeed macrophages. On the contrary, none of the CD103+ cells 
express the receptor, definitely excluding that CX3CR1+ cells are dendritic cells. 
 We first investigated the composition of gut resident leukocytes in WT and KO mice 
under homeostatic conditions. To do this, we performed FACS analysis on healthy colonic 
tissue and we analyzed the percentage of CD45+ leukocytes, PMN and macrophages. In steady 
state conditions, we found no differences between WT and KO mice. Indeed, the percentage 
of the analyzed cells was almost the same between the two populations (figure 20). We were 
particularly interested in the behavior of macrophages. For this reason we evaluated different 
types of macrophages in order to analyze in depth this cell subset. We detected F4/80+ and 
CD11b+ macrophages and gating on these cells we analyzed the percentage of Ly6Chigh cells to 
determine the rate of newly recruited macrophages. As shown in figure 20, there were no 
differences during the different steps of differentiation of Ly6C+ monocytes in healthy colon. 
Finally, we looked at CX3CR1+ cells and no differences were appreciated between WT and 
KO.  
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Fig. 20. Analysis of leukocytes in the healthy colon of WT and KO mice. The FACS strategy 
shown above was used for all the future experiments. The first gate characterized the global CD45+ 
infiltrate. Based on CD45+ cells, PMN and macrophages were detected by the expression of Ly6G or 
F4/80, respectively. From the latter population, macrophages expressing Ly6C+ cells and CX3CR1+ 
were studied. In steady state conditions, there were no differences in the accumulation of different 
immune cell types in the colon of WT and KO mice. 
 
IL10 and CX3CL1 signalling in CX3CR1+ macrophages  
A very important feature of CX3CR1+ macrophages is their ability to maintain 
homeostasis and to avoid the rise of aberrant inflammation. CX3CR1+ Mφ produce a great 
amount of the anti-inflammatory cytokine IL-10. Recently, Zigmond et al., demonstrated that 
the production of IL-10 is not sufficient to maintain homeostasis: CX3CR1+ Mφ need to sense 
the IL-10 they produce with IL-10 receptor (IL-10R) [34]. In order to confirm these results, 
we tested CX3CR1+ Mφ for the production of IL-10 and for their ability to respond to it. We 
harvested bone marrow derived macrophages (BMDM), spleen and colonic macrophages from 
both CX3CR1GFP/+ and CX3CR1GFP/GFP mice and evaluated the mRNA production of IL-10 
and IL-10R. As shown in figure 21, panel A, we confirmed that macrophages produce both the 
cytokine and its receptor. To evaluate if the link between IL-10 and its receptor was functional 
and able to generate a correct signalling, we performed a phospho-flow assay to evaluate 
STAT3 phosphorylation after IL-10 stimulation (panel B). Macrophages from both WT and 
KO mice phosphorylated pSTAT3 after 5 minutes of stimulation in a super imposable manner. 
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Fig 21: CX3CR1+ macrophages are able to produce and to sense IL10 (A) RNA quantification 
of IL10 and its receptor IL10R in FACS sorted CX3CR1+ BMDM, spleen and colonic macrophages of 
CX3CR1GFP/+ and CX3CR1GFP/GFP mice. (B) Phospho-flow of spleen macrophages stimulated with 
IL10. pSTAT3 is phosphorylated after 5 minutes of stimulation and sustained thereafter, but decreases 
at 120 minutes.  
 
We next demonstrated that the CX3CR1 signalling also involves STAT3. Macrophages 
harvested from the spleen of both WT and KO mice were stimulated with fractalkine (FKN) 
for 5, 30 or 120 minutes. As shown in figure 22, WT mice generated a response and pSTAT3 
was phosphorylated already at 5 min. In contrast, no phosphorylation was detectable in KO 
mice, as expected. This finding also confirmed that CX3CR1 is the only receptor for FKN.  
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Fig.22: STAT3 phosphorylation after stimulation with CX3CL1. Spleen macrophages were 
used to evaluate STAT1 and STAT3 phosphorylation after stimulation with FKN. STAT1 
phosphorilation is undetectable in both WT and KO mice at any time point. In contrast, WT mice, 
after 5 minutes of stimulation produce a response, inducing the phosphorylation of STAT3 while no 
response is observed in KO mice at any time point.  
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Acute colitis induced by DSS 
Mucosal CX3CR1+ macrophages were investigated in a model of DSS-induced colitis. 
The aim was to understand if the lack of the receptor induced any difference during colitis. 
Both CX3CR1+/GFP and CX3CR1GFP/GFP mice were fed with DSS for seven days; along this 
period, loss of weight was monitored daily. At the end of the treatment mice were sacrificed 
and colon isolated to evaluate inflammation. KO mice showed higher signs of inflammation 
and lost weight rapidly, starting from day 5. Moreover, colon length was significantly reduced 
and evaluation of the histological score revealed how inflammation affects more severely the 
mucosa: colonic architecture was lost, there was a massive infiltration of leukocytes in the 
crypts that were, often, completely subverted (figure 23).  
 
Fig. 23: Histological analysis of DSS-treated WT and KO mice. Evident signs of colitis are 
visible in panel A; WT mice show a lower rate of inflammation compared to KO mice in terms of 
colon length, colitis score and loss of weight. *p<0,05, **p<0,01 
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In steady state, CX3CR1+ macrophages are important in the maintenance of 
homeostasis. Considering the higher grade of inflammation in KO mice, compared to WT, we 
initially thought that macrophages of KO mice were not able to control inflammation because 
of the loss of functional CX3CR1+ cells in the mucosa. Surprisingly, KO mice presented a 
higher number of macrophages after DSS treatment. Macrophages are recruited, as reported 
in the literature, mainly via the CCR2-CCL2 axis. The absence of the CX3CR1 receptor did 
not prevent the recruitment of macrophages but prevented their protective functions. 
Therefore, more Mφ were recalled during inflammation in the attempt to obtain a response 
from these cells that can not be provided (figure 24).  
 
 
Fig. 24: Recruitment of CX3CR1+ macrophages in the colon during acute DSS-induced 
colitis. Immunofluorescence of CX3CR1 macrophages after treatment with DSS (day 7) shows how 
CX3CR1 GFP/GFP macrophages in KO mice are more abundant compared to WT. Magnification 
20X, CX3CR1 green, DAPI blue; ***p<0,001 
 
Recovery from colitis 
in view of the inability of KO mice to correctly control inflammation, and considering 
the fact that “cancer is a wound that never heals”, we analysed the behaviour of both 
CX3CR1+/GFP and CX3CR1GFP/GFP mice in the process of resolution of colitis. The results 
demonstrate that KO mice are unable to resolve inflammation. At day 10, when WT mice start 
to recover, KO mice still displayed high signs of inflammation in terms of both loss of weight 
and colon length (figure 25). 
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Fig. 25: Percentage of body weight and colon length of WT and KO mice at recovery, 
after treatment with DSS for 7 days. WT mice at day 10 began to recover from inflammation and 
at day 13 they had completely restored while KO mice still showed signs of inflammation. *p<0,05, 
**p<0,01, ***p<0,001 
 
Moreover, we analysed the presence of different leukocyte populations in the intestine, 
along the experiment: at day 7, after treatment with DSS, at day 10, when WT mice begin to 
recover, and at day 13, when WT mice are completely healed (figure 26). We found that KO 
mice have an abundant macrophage infiltration: the absolute number of both macrophages and 
inflammatory monocytes is augmented in KO mice starting from day 10. Moreover, the 
percentage of macrophages and, in particular, of CX3CR1+ Mφ, is higher in KO mice since 
day 7. Of note, the higher number of CX3CR1+ and of Ly6C+ monocytes underlines the 
current opinion that inflammatory monocytes give rise to CX3CR1+ macrophages during 
inflammation [28].  
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Fig. 26: Leukocyte recruitment in acute colitis and recovery. FACS analysis of colon samples 
from WT (white) and KO (green) mice: counts of different leukocyte populations (panel A), 
population percentages (panel B) and CX3CR1+ cells counts and percentages (panel C) at day 7 (at 
the end of DSS treatment) and in recovery at day 10 and 13. Representative results from three 
independent experiments are shown. *p<0,05 
 
We next extracted RNA from colon tissues and analysed the mRNA levels of several 
biological mediators at day 10 and 13, comparing WT and KO mice and also comparing them 
with untreated mice. At day 10, in line with the histological observations, both WT and KO 
mice showed signs of inflammation: in particular KO mice displayed high level of the anti-
inflammatory cytokines IL-10 and IL-20. The higher production of IL-10 in KO mice is likely 
to be an attempt to cope inflammation. However, other pathways seem to be involved in the 
intestine control of inflammation. Indeed, KO mice produced lower levels of heme-oxygenase-
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1 (hemox-1) compared to WT. At day 13 WT mice had completely restored from colitis, 
while KO mice still showed high levels of inflammation: we found that the mRNA levels of 
TNF-α, IL-6, IL-1β, IFN-γ and COX2, together with the anti-inflammatory cytokines, were 
still significantly over-expressed in KO mice at day 13 (figure 27).  
 
 
Fig. 27: mRNA expression of pro and anti-inflammatory mediators at recovery from 
DSS-induced acute colitis. At day 10 both WT and KO mice still show signs of inflammation. KO 
mice try to switch off inflammation producing higher level of anti-inflammatory cytokines. However, 
hemox-1 is down-regulated in KO compared to WT mice. At day 13, WT mice had completely 
restored while KO mice still show signs of inflammation. *p<0,05, **p<0,01, ***p<0,001 
 
Considering the results obtained with the analysis of hemox-1, we analysed the protein 
levels present in the colonic mucosa at day 10 in both WT and KO mice. Figure 28 shows that 
protein production, as well as the mRNA expression, is dramatically down regulated in KO 
mice.  
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Fig. 28: Western blot of heme-oxygenase-1 at day 10 of recovery from DSS-induced 
acute colitis. WT mice produced higher levels of hemox-1 compared to KO mice in the attempt to 
control tissue damage and inflammation. Hemox-1 production is strongly impaired in KO mice. 
 
Taken together these results suggest an inability of KO mice to control inflammation: 
if CX3CR1 is not functional, an important resolution checkpoint for the colonic mucosa is lost 
and this results in an abundant recruitment of pro-inflammatory monocytes and release of pro-
inflammatory cytokines, eventually leading to an aberrant inflammatory response.  
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In vitro analysis of CX3CR1+ macrophages 
To further investigate the role of the CX3CR1 receptor in the modulation of 
inflammation, we performed in vitro studies with bone marrow derived macrophages (BMDM) 
from both CX3CR1+/GFP and CX3CR1GFP/GFP mice. Bone marrow CX3CR1+ cells were FACS 
sorted and induced to differentiate for seven days with M-CSF. Macrophages were either left 
untreated, or stimulated with FKN, or with LPS or stimulated with both FKN and LPS. In the 
latter group, cells were pre-treated with FKN for 18 hours and then with LPS for 4 hours. 
After treatment, we analysed the mRNA expression of pro and anti-inflammatory mediators. 
We found that both WT and KO mice were able to constitutively produce appreciable 
levels of TGF-β, hemox-1, IL-19 and IL-10. After treatment with FKN, hemox-1 levels were 
significantly increased in WT, but not in KO mice, and this increment was further augmented 
when cells were stimulated with the combination of FKN and LPS, suggesting a synergism of 
the two stimuli. As observed in vivo, KO mice expressed higher levels of IL-10 family members 
after treatment with LPS, but were unable to respond to FKN and to increase the expression 
of Hemox-1. In addition, TGF-β production was stimulated by FKN but not by LPS in WT 
mice, while KO were unable to respond to this stimulus.  
Overall, these results provided the interesting information that FKN-signalling through 
its specific receptor induced the production of TGF-β and hemox-1, as well as the production 
of IL-10, highlighting the important role of this chemokine-receptor axis in limiting 
inflammation.  
Finally, we analysed the mRNA levels of some pro-inflammatory mediators finding a 
higher response in KO mice for IL-6 transcripts (figure 29).  
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Fig.29: mRNA quantification of pro and anti-inflammatory mediators in FACS sorted 
BM-derived CX3CR1+ macrophages. Bone marrow derived macrophages were FACS sorted and 
then divided into four groups: not treated (NT), stimulated with FKN, stimulated with LPS (LPS), 
stimulated with both Fractalkine and LPS (LPS-FKN). WT and KO were compared. Macrophages 
were stimulated with FKN for 18h and then with LPS for 4h. Representative results from three 
independent experiments are shown. *p<0,05, **p<0,01, ***p<0,001 
 
Furthermore, we monitored protein production of some cytokines such as TNF-α, IL-
6 and IL-10 in ELISA assay and we obtained similar results as observed in RT-PCR: KO mice 
produced more inflammatory mediators and more IL-10 compared to WT retracing perfectly 
what happened in vivo (figure 30). 
Fig.30: ELISA assay of pro and anti-inflammatory mediators in FACS sorted BM-derived 
CX3CR1+ macrophages. Cytokine production was detected in ELISA assay. Macrophages were 
stimulated with FKN for 18h and then with LPS for 4h. WT and KO cells were compared. KO 
macrophages displayed a higher response to the inflammatory stimulus and, in the case of TNF-α, they 
were not able to switch off inflammation after the administration of FKN. IL-10 is over-expressed in 
KO macrophages in the attempt to limit inflammation. *p<0,05, **p<0,01, ***p<0,001 
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To further confirm the difference in the production of inflammatory cytokines between 
WT and KO mice, we decided to investigate the behaviour of peritoneal elicited macrophages 
(PEC). We injected mice with thioglycolate, a yeast extract, and performed the same type of 
experiment used for BMDM. As shown in figure 31, using PEC we were able to better 
appreciate the differences between WT and KO. PEC from KO mice produced significantly 
higher levels of IL-1β, IL-6, IFN-γ, IL-12 and COX2.  
Fig.31: mRNA quantification of pro -inflammatory mediators in peritoneal 
macrophages. Peritoneal elicited cells (PEC) were FACS sorted and then divided into four groups: 
not treated (NT), stimulated with FKN, stimulated with LPS (LPS), stimulated with both Fractalkine 
and LPS (LPS-FKN). WT and KO PEC were compared. Macrophages were stimulated with FKN for 
18h and then with LPS for 4h. Representative results from three independent experiments are shown. 
*p<0,05, **p<0,01, ***p<0,001 
 
The above findings demonstrated that macrophages from KO mice have an aberrant 
inflammatory response. They displayed a greater response to stimuli and produced higher 
amount of pro-inflammatory mediators; furthermore they revealed an inability to produce 
adequately amount of anti-inflammatory mediators such as hemox-1, except for IL10 that was 
produced in a CX3CR1-independent manner.  
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Next, we wanted to demonstrate also in vitro that KO mice are not able to recover 
from inflammation as fast as WT mice do. Therefore, we stimulated BMDMs with LPS for 4 
hours, we washed out the stimulus and we prolonged the incubation for 18 hours. As shown 
in figure 32 there was a delay in the recovery of KO mice. After 22 hours from LPS treatment, 
macrophages from KO mice still produced high levels of pro-inflammatory mediators, such as 
TNF-α, IL-1β, IL-6 and iNOS. In turn, they were unable to produce TGF-β and hemox-1 at 
the same levels found in WT mice. 
 
 
Fig.32: mRNA quantification of pro and anti-inflammatory mediators in FACS sorted 
BM-derived CX3CR1+ macrophages after prolonged LPS stimulation. Bone marrow 
derived macrophages were sorted and WT and KO cells were compared. Macrophages were 
stimulated with LPS for 4h then washed and cultures prolonged for 18h in order to replicate the colitis 
model of recovery. (A) KO macrophages show higher response compared to WT; indeed in KO 
macrophages the inflammatory cytokines were still over expressed compared to WT cells. (B) On the 
contrary, TGF-β and Hemox-1 were modulate in WT mice but not in KO. *p<0,05, **p<0,01,  
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Colitis associated cancer 
So far, our results demonstrated that loss of the chemokine receptor CX3CR1 leads to 
an altered response of mucosal macrophages in the control of inflammation during colitis and 
during the process of recovery. Our main interest was to evaluate whether this increased 
inflammation had an impact on colorectal carcinogenesis. For this reason we developed a model 
of colitis-associated cancer (CAC) in which CX3CR1+/GFP and CX3CR1GFP/GFP mice were 
intra-peritoneally injected with the carcinogen azoxymethane (AOM) and a week after, were 
fed with DSS followed by water for two weeks for a total of three cycles. Weekly, during the 
treatment, weight, stool bleeding and consistency were assessed (figure 33).
 
 
 
 
 
 
 
 
 
Fig. 33: Disease Activity Index (DAI) in the mouse model of colitis-associated cancer: 
Twice a week weight and stool consistency of mice were detected. Disease activity index (D.A.I.) and 
weight were recorded according to parameters reported in the table. °p<0,05, + p<0,01, *p<0,001 
Weight loss Score Stool blood Score Stool consistency Score 
< 1% 0 Negative 0 Normal 0 
1-5% 1 Positive to Hemoccult 1 Soft 1 
5-10% 2 Visible blood 2 Very soft 2 
10-15% 3 Gross bleeding 3 Diarrhea 3 
> 15% 4     
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After the first cycle of DSS, both KO and WT mice showed loss in weight and signs of 
bleeding in addition to a production of soft stools. However, during the recovery with water, 
WT mice gained weight, stopped bleeding and stools became normal again. Instead, KO mice 
failed to recover: they kept losing weight and their stools resulted very soft and bleeding. 
During further cycles, the difference between WT and KO became even stronger, in particular 
for their inability to regain weight. At the end of the experiment, after 70 days, colons were 
harvested to be analysed. KO mice showed higher signs of inflammations: colitis score and 
colon length indicated that they had a stronger disease compared to WT mice and, indeed, they 
had a higher percentage of adenomas and a lower survival rate (figure 34). 
 
 
Fig.34: Histological analysis of treated mice. KO mice have a lower survival rate and developed 
higher numbers of polyps compared to WT mice; in contrast, WT mice show a lower rate of 
inflammation in terms of colon length and colitis score. *p<0,05, **p<0,01, ***p<0,001 
 
As observed in the model of acute colitis, also in the CAC model KO mice recruited 
more macrophages in the adenomatous tissue. We were able to detect inside the polyp, 
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CX3CR1+ Mφ, while at adenomatous border macrophages were mostly F4/80+ CX3CR1-, 
confirming that inflammatory and resident macrophages have the same precursor and that they 
differentiate in a context-dependent manner. In addition, we demonstrated that in polyps there 
was a higher infiltration of CX3CR1+ macrophages in KO mice (figure 35.). Moreover, FACS 
analysis revealed that Ly6C+ monocytes as well as TLR2+ macrophages were more abundant 
in the colonic mucosa of KO mice (figure 36).  
 
 
 
 
Fig.35: Recruitment of CX3CR1+ macrophages in polyps. Inflammatory and resident 
macrophages have the same precursor and they differentiate in a context-dependent fashion. (B) As 
observed for acute colitis, immunofluorescence of CX3CR1 macrophages after treatment with 
AOM/DSS shows that CX3CR1GFP/GFP macrophages in KO mice are more abundant compared to WT 
mice. Magnification 20X, CX3CR1 green, F4/80 red, DAPI blue; ***p<0,001 
 
 
A 
B 
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Fig.36: Macrophage recruitment in the CAC model. FACS analysis of leukocyte infiltrate in 
the polyps from WT (white) and KO (green) mice: the results show that KO mice had higher 
percentage of macrophages. Representative results from three independent experiments are shown. 
*p<0,05, **p<0,01, ***p<0,001 
 
To better understand what happened in the colonic mucosa, we dissected polyps from 
the inflamed colon and separately analysed the mRNA levels of pro-inflammatory cytokines 
and anti-inflammatory mediators (figure 37). 
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Fig. 37: mRNA expression of pro and anti-inflammatory mediators in the polyps and 
colon tissues of mice in the CAC model. The adenomatous polyps were separated from the rest 
of the colon and the two specimens were analyzed for the expression of different pro-inflammatory 
(A) or anti-inflammatory (B) cytokines or mediators. *p<0,05, **p<0,01, ***p<0,001 
 
As shown in figure 37 (panel A) KO mice produced higher levels of inflammatory 
cytokines not only in the adenomatous tissue, but also in the inflamed mucosa. According to 
the extrinsic pathway of cancer-related inflammation, this higher grade of inflammation 
induced the development of more polyps. The higher rate of polyps in KO mice is in line with 
the higher levels of pro-inflammatory cytokines produced inside the transformed tissue.  
In panel B it is represented the expression of anti-inflammatory cytokines and 
mediators. It is important to note that IL-10 family members were over-expressed in KO mice. 
CX3CR1 macrophages are key producers of IL-10 in the intestinal mucosa in a CX3CR1-
independent manner. Indeed, KO mice are able to produce IL-10 (and to sense it, thanks to 
the expression of IL-10R). As KO mice have more inflammation compared to WT mice, they 
try to switch off inflammation by producing more IL-10, in order to limit tissue damage. 
Interestingly, IL-23 is down-regulated in KO mice. IL-23 is an important mediator in the 
colonic mucosa; it is produced by CX3CR1 macrophages and it is essential to stimulate the 
production of IL-22 by type 2 innate lymphoid cell (ILC2). However, there were no significant 
differences in the production of IL-22 between WT and KO mice, indicating that other cell 
types are involved in this process. 
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Finally, we analysed the mRNA expression of TGF-β and Hemo-oxygenase-1 and we 
found that these were the only two down-regulated molecules in the adenomatous tissue in 
KO mice. 
 
Genetic model of colitis associated cancer 
We decided to investigate a genetic model of intestinal polyposis in order to confirm 
the data obtained with the sporadic model of CAC. APCMin mice carry a mutation in the APC 
gene leading to a spontaneous development of polyps in the small intestine. In inflammatory 
conditions, such as after DSS administration, APCMin mice can develop polyps also in the 
colonic mucosa. We crossed CX3CR1GFP/+ or CX3CR1GFP/GFP mice with APCMin mice and 
generated mice that were either competent or not for the expression of CX3CR1 and also 
carried the APCMin gene. Mice were administered DSS for one week and then water for four 
weeks.  At the end of the experiment, colons were harvested in order to assess histological 
parameters (figure 38). As observed in the previous sporadic model of CAC, KO mice 
(CX3CR1GFP/GFP-APCMin) showed higher signs of inflammation and a greater number of polyps 
compared with WT mice (CX3CR1GFP/+-APCMin). Indeed, colons were shorter in KO mice 
and they showed a higher D.A.I. score. Moreover, they were not able to regain weight after 
DSS administration as WT mice did.  
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Fig.38: Histological analysis of DSS treated WT mice (CX3CR1GFP/+-APCMin) and KO mice 
(CX3CR1GFP/GFP-APCMin). Colons were harvested after five weeks from the beginning of the 
experiment, length was measured and the percentage of adenomatous tissue was calculated on the 
whole colon. KO mice showed higher signs of inflammation, shortness in colon length and a higher 
number of polyps. Disease Activity Index (DAI) and percentage of body weight of treated mice were 
analyzed weekly. *p<0,05, **p<0,01, ***p<0,001, , ****p<0,0001 
 
We then investigated the composition of the tumor microenvironment in terms of both 
cytokine expression and leukocyte infiltration. As shown in figure 39, KO mice had higher 
number of CD45+ cells and, in particular, more inflammatory (Ly6C+) macrophages and 
CX3CR1+ Mφ.  
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Fig.39: Macrophage infiltration in colon tissues of DSS-treated WT mice (CX3CR1GFP/+-
APCMin) and KO mice (CX3CR1GFP/GFP-APCMin). FACS analysis of polyps from WT (white) and 
KO (green) mice. In KO mice higher number of CD45+ cells are recruited, in particular CX3CR1+ 
macrophages and Ly6Chigh inflammatory monocytes. (A) the results are shown as absolute number of 
cells; (B) the results are shown as percentage of each sub-population. Representative results from two 
independent experiments. *p<0,05, **p<0,01, ***p<0,001 
 
The mRNA analysis of the colonic mucosa revealed the same results obtained in the 
AOM-DSS model of CAC. Indeed, KO mice were not able to properly face inflammation and 
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this resulted in an aberrant inflammatory response. Inflammatory cytokines such as IL-6, IFNγ 
were upregulated in KO mice in both polyps and colonic tissue. In general, all the inflammatory 
cytokines appeared more expressed in the adenomatous tissue of KO mice (figure 40). 
Next, we examined the expression of anti-inflammatory mediators. As it was for the 
previous model, also in this case KO mice attempted to switch off inflammation by producing 
higher amount of IL-10 that resulted upregulated in both polyps and inflamed tissues. In 
addition, IL-19 was higher in KO mice, although not in a significantly way, while no differences 
could be appreciated in the expression of IL-20 and IL-10 receptor. On the contrary a very 
significant difference was found in the expression of both TGFβ and hemox-1 in the 
transformed tissue, confirming and extending our observation in the AOM-DSS model.  
In conclusion, we demonstrated that the lack of functional CX3CR1 receptor leads to 
the same phenotype either in the sporadic model of colitis-induced cancer and in the genetic 
APCMin model. 
Fig.40: mRNA expression of pro and anti-inflammatory cytokines in the polyps and 
colon tissues of DSS-treated WT mice (CX3CR1GFP/+-APCMin) and KO mice 
(CX3CR1GFP/GFP-APCMin). The adenomatous tissue were separated from the rest of the colon and 
the two specimens were independently analyzed for the expression of different pro-inflammatory (A) 
or anti-inflammatory (B) cytokines or molecules. *p<0,05, **p<0,01, ***p<0,001 
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Induction of heme-oxygenase-1 in CAC 
 
Having seen a decrease in the production of hemox-1 in KO mice (CX3CR1GFP/GFP), 
both in vivo and in vitro, we decided to investigate in depth the mechanisms that link the 
CX3CR1 receptor and this molecule.   We performed an AOM-DSS experiment of colitis-
associated cancer in which CXRCR1GFP/+ and CX3CR1GFP/GFP mice were injected with a 
chemical inducer of hemox-1, four times a week following the scheme in figure 17.  
 
Fig. 17: Scheme of AOM-DSS experiment. Arrows indicate cobalt protoporphyrin IX (coPP) 
injection. 
 
Cobalt protoporphyrin IX (coPP) is a powerful inducer of hemox-1 [67, 68]. We 
decided to administer the drug at day -1, 0, 3 and 6 of each cycle of DSS in order to stimulate 
the production of hemox-1 and its protective effects during the presence of the inflammatory 
stimulus. Mice were divided into four groups: WT and KO mice were treated with coPP or 
with vehicle. Weekly along the experiment, weight, stool consistency and bleeding were 
assessed in order to determine the disease activity index. Results are reported in figure 41.  
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Fig. 41: Disease score in the AOM/DSS experiment upon treatment with coPP: (A) Disease 
Activity Index (D.A.I.). Every week stool bleeding and consistency were analyzed in mice treated with 
coPP, disease severity was milder compared to untreated mice and there was no difference between 
WT and KO cop-treated mice. (B) Percentage of body weight of treated mice during treatment.  
 
As shown in figure 41, treatment with coPP was able to switch off inflammation in both 
WT and KO mice while in mice treated with vehicle the difference observed between WT and 
KO were fully conformed to the previous experiment. Indeed, in mice treated with coPP, 
D.A.I. score was almost always close to 0 and KO mice showed a regain in weight similar to 
that of WT mice. At the end of the experiment, colons were harvested for analysis. As shown 
in figure 42, the phenotype of coPP-treated KO mice was completely reverted: no signs of 
inflammation were visible and a very low number of polyps were detected. Of note, also in 
coPP-treated WT mice there was an amelioration of the severity of the disease. Indeed, after 
coPP administration KO and WT mice were indistinguishable and healthy. 
 
Fig.42: Histological analysis of treated mice. Mice treated with coPP revert the phenotype of 
the disease: for both WT and KO mice, colitis score is reduced. The number of polyps is dramatically 
decreased and colon length is restored. *p<0,05, **p<0,01, ***p<0,001, ****p<0,0001 
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To verify that the changes observed in phenotype were due to the induction of hemox-
1, we performed a western blot analysis to confirm the over-expression of hemox-1 after 
treatment with coPP. Shown in figure 43, panel A, hemox-1 in vehicle-treated KO mice was 
significantly lower than in WT mice. However, after coPP treatment, both KO and WT mice 
upregulated hemox-1 to a similar level. To corroborate the anti-inflammatory properties of 
hemox-1 we performed a gene expression of colon tissues from mice treated with either 
vehicle or coPP. In panel B it is reported the mRNA expression of some pro-inflammatory 
cytokines. While KO mice treated with vehicle showed higher levels of inflammation, 
treatment with coPP decreased the amount of pro-inflammatory cytokines in both WT and 
KO mice, confirming the anti-inflammatory effect of hemox-1.  
Overall, these results demonstrate that when hemox-1 was induced via a 
pharmacological stimulus, the differences in the inflammatory status and disease score between 
the two mouse strains were abrogated. Thus, we conclude that the increased inflammation 
found in KO mice lacking the receptor CX3CR1 is likely due to the inability to upregulate 
hemox-1 via the FKN-CX3CR1 axis. 
Fig.43: Molecular analysis of heme-oxygenase-1 and anti-inflammatory cytokines in 
coPP-treated mice. Treated colons were analyzed by western blot to detect hemox-1 (A). WT and 
KO mice treated with vehicle maintain the differences shown above, while the expression of hemox-1 
in coPP-treated mice is increased and no differences are observed between WT and KO mice. (B) 
mRNA expression of pro-inflammatory mediators is increased in KO mice treated with vehicle. The 
treatment with coPP turns off inflammation. *p<0,05, **p<0,01, ***p<0,001  
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Microbiome influence in colitis-associated cancer 
 
Hemox-1 is involved in the clearance of bacteria in the intestinal lumen. Considering 
our results obtained in vivo, we questioned if the ability to phagocytose was impaired in Mφ of 
KO mice. To do this, we harvested PEC from both WT and KO mice and we tested their 
aptitude to phagocytose. Mφ were co-cultured with beads coated with LPS for 1 hour and the 
percentage of beads phagocytosed versus the overall number of cells was evaluated as reported 
in figure 44. As it was expected, KO mice showed a significant reduced phagocytoses. 
 
 
 
Fig.44: Phagocytosis. Hemox-1 is involved in the process of phagocytosis. Left panel shows an 
explicative picture of KO macrophages eating beads coated with LPS. On the right panel the graph 
highlights the differences in the phagocytosis ratio between WT and KO Mφ. (p<0,05) 
 
Considering the differences emerged in the phagocytosis assay, we performed a deep 
analysis of the intestinal microbiota of WT and KO mice treated with the AOM-DSS protocol. 
We compared stools of mice at week 0, at week 2 (after the first cycle of DSS) and at week 10 
(at the sacrifice). We sequenced 16S rRNA gene amplicons obtained from faecal metagenomic 
DNA and we compared WT and KO mice. We first analysed two ecological parameters: the 
alpha and beta diversity. Alpha diversity was studies through Chao 1 coefficient, which 
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estimates the intra-sample richness of operational taxonomic units (OTUs). Beta diversity, 
which is the inter-sample measurement of differences in OTUs diversity, was evaluated by 
using weighted (quantitative) and unweighted (qualitative) Unifrac algorithms. Unifranc is an 
algorithm that considers phylogenetic distances among OTUs; in particular, unweighted 
Unifrac considers the presence/absence of a specific OTU among samples, whereas weighted 
Unifrac considers OUT relative abundance. As shown in figure 45, at day 0, there were no 
differences in alpha diversity in both WT and KO mice. On the contrary, during the treatment 
with DSS, WT mice displayed higher rate of alpha diversity compared to KO. Both two strains 
tried to restore their original microbiota composition over time but, at sacrifice, WT mice still 
revealed higher alpha diversity. The treatment with DSS destroyed the integrity of mucosal 
barrier, generating inflammation. Therefore, during the administration of DSS an immune 
response is engaged in order to eliminate the bacteria that have invaded the tissue. KO mice 
displayed higher rate of inflammation respect to WT and this aberrant response cause an 
impairment in alpha diversity that results higher in WT. 
 
Fig.45: Alpha diversity during AOM-DSS treatment. At the beginning of the experiment, when 
mice were still untreated and, consequently, healthy, there were no differences in alpha diversity 
between WT and KO mice. This means that there were no significant differences in bacterial 
taxonomic richness of the healthy intestine between WT and KO mice. After the first cycle of DSS, 
KO mice showed a reduced alpha diversity that was maintained until sacrifice. Plausibly, the iper-
stimulation of the immune response in KO mice was the reason for lower alpha diversity. 
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Beta diversity analyses allow the comparison of the overall taxonomic microbiota 
composition among sample. Figure 46 show that samples from KO mice are widely scatterd in 
the beta-deversity plot, indicating higher inter-sample diversity of KO than WT mice . We can 
speculate that the microbiota of KO mice is instable due to host immune impairment. 
 
Fig. 46: Beta diversity analysis of faecal microbiota according to Weighted (top panels) 
and unweighted (lower panels) Unifrac. The three most significant principal coordinate have 
been plotted. Samples from WT and KO mice are shown in red and blue respectively. 
 
The relative abundance of specific bacterial taxa was analysed at level of phylum, family 
and genus in the three time point considered. At day 0 almost no differences were detectable 
between WT and KO; on the contrary, one week after DSS administration, more differences 
became visible. In particular, at sacrifice, three genera were markedly different between KO 
and WT samples: Akkermansia, Lachnospira and Bacteroides (figure 47).  
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Fig. 47: 16s sequencing. Heat-map representing relative abundance of bacterial taxa of faecal 
samples. The taxonomic levels of phylum, family and genus were considered. At sacrifice, the main 
differences between the microbiota composition of KO and WT mice in genera Akkermansia, Lachnospira 
and Bacteroides. 
 
Bacteroides is a Gram negative genus that include bacteria associated to health benefit for 
the host [151]. We evaluated their relative abundance in the samples at day 0 and at sacrifice 
but there was little difference between WT and KO, probably because the relative abundance 
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of this bacterium was particularly low. Lachnospira is a member of the Gram positive class 
Clostridiales; these bacteria are considered among the most active components of the intestinal 
microbiota and represent part of the most important intestinal producers of butyrate, a short 
chain fatty acid that protect mucosa and regulate immune responses in the gut. We tested the 
abundance of Lachnospira by qPCRby qPCR but, despite a tendency, no statistically significant 
differences between WT and KO mice were found. On the contrary, when we tested the 
relative presence of Akkermansia, we found a significant decrease in KO compared to WT mice. 
The presence of Akkermansia in untreated samples was identical between WT and KO mice but, 
at sacrifice, WT mice had a higher presence of this bacterium compared to KO mice (figure 
48). Akkermansia is a Gram negative bacterium able which efficiently degrade intestinal mucins. 
Its role in IBD is now under investigation but it was reported that in both UC and CD the 
presence of Akkermansia is drastically diminishing [53].  
Fig.48: Relative abundance of genera Akkermansia, Lachnospira and Bacteroides. Data refer to the 
relative proportion of target bacteria relative to total bacteria calculated by qPCR using genus specific 
and universal (Eub) primer targeting 16S rRNA gene. Only the relative abundance of Akkermansia was 
significantly differentbetween KO and WT mice at sacrifice. 
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In order to test if the intestinal microbiota can influence the microenvironment, we 
performed an AOM-DSS experiment co-housing WT and KO mice. Mice were put together 
at the time of weaning in cages with two mice WT and two mice KO. Weight and D.A.I. score 
were registered every week and are represented in figure 49 compared with a classical non-co-
housed AOM-DSS experiment. It was clear that the co-housing altered the behaviour of mice 
during treatment: both weight and D.A.I. did not change between WT and KO mice indicating 
that gut microbiota of the two strains is able to mutually influence each other. 
   
Fig. 49: Co-housing in the AOM-DSS model: Panel A reports weight of mice during treatment 
while in panel B it is represented the disease activity index (D.A.I.). The grey lines represent mice 
treated with the AOM-DSS protocol without co-housing while the red and green lines represent WT 
and KO mice co-housed. In both panels it is evident how co-housing altered the response to treatment. 
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At the end of the experiment, colons were harvested, measured and polyps and colitis 
score were assessed. If compared with the classical AOM-DSS experiment, both WT and KO 
mice displayed a lower percentage of adenomatous tissue and of colitis score together with a 
higher colon length. Nevertheless, some differences remained between WT and KO mice in 
term of polyps’ formation and colon length (figure 50).  
Fig. 50: Histologic analyses of co-housed mice: in green are represented co-housed WT and 
KO mice of the AOM-DSS experiment. Despite some differences remained between WT and KO 
mice, they were more similar if compared to the classical AOM-DSS experiment (*p<0,05; 
**p<0,01; ***p<0,001; ****p<0,0001).  
 
In order to better understand how the co-housing could affect weight, D.A.I. and 
polyps formation, we extracted mRNA from polyps and we determined the levels of both pro 
and anti-inflammatory cytokines. As shown in figure 51, the differences observed in the 
classical AOM-DSS model became less evident. In the top panel the only molecule down-
regulated in KO mice was hemox-1 and the only pro-inflammatory cytokine was IL-12. These 
preliminary results indicate that the microbiome is mutually influenced between WT and KO 
mice. This resulted in an attenuation of the severity of the disease reflected in a lower rate of 
polyps, colitis score and in a higher capability to regain weight after DSS administration. In 
support to this hypothesis, both pro and anti-inflammatory cytokines were modulated in both 
WT and KO mice and no significantly alterations could be appreciable. In this landscape only 
hemox-1 remained down-regulated in KO mice highlighting the need of the receptor to 
activate this crucial signalling. Indeed, KO mice exhibited higher rate of polyps even if co-
housed. (However, a microbiota profiling of co-housed mice would be necessary).  
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Fig. 51: Pro and anti-inflammatory cytokines in the colonic mucosa of co-housed mice 
during the AOM-DSS treatment. In both panels there are a few differences between WT and KO 
mice. It is important to note in panel A that hemox-1 is down-regulated in KO mice as it was in the 
classical AOM-DSS model. Therefore, even considering the importance of the microbiome, in this 
context this enzyme assumes a crucial role for tumour development.  
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Discussion  
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The intestine is an exclusive site able to maintain the balance between immune system 
activation and tolerance against the very huge amount of harmless antigens that are in contact 
with the intestinal lumen, including food antigens and microflora. During inflammation, the 
immune system has to trigger a pro-inflammatory response and to be able to restore 
homeostasis in order to avoid aberrant responses that can lead to chronic inflammation and 
tissue injury. In this complex landscape, mononuclear phagocytes, and in particular CX3CR1+ 
macrophages, represent the most abundant population and exert a key role in the maintenance 
of homeostasis. 
Our aim was to investigate the role of CX3CR1+ macrophages in both steady state and 
inflammation with a particular focus on the resolution of inflammation and the development 
of intestinal tumorigenesis. Indeed an impaired resolution could favor tumor development. 
We first characterized the features of CX3CR1+ cells in the colonic mucosa. We 
defined them as resident macrophages expressing high levels of the CX3CR1 receptor together 
with F4/80, CD11b and CD64 reproducing the data obtained by Bain and colleagues [10]. 
CX3CR1+ MO have the primary purpose to maintain homeostasis in the complex intestinal 
microenvironment. It is well known the key role that IL-10 plays in this context; therefore we 
tested mucosal macrophages, in mice deficient or competent for the CX3CR1 receptor, for 
their ability to produce IL-10 and, according to the recent finding of Zigmond and colleagues 
{Zigmond, 2014 #266, to sense IL-10 thanks to the expression of its receptor. They 
demonstrated that loss of the IL-10 receptor causes severe colitis. In the gut, CX3CR1+ Mφ 
produce IL-10 in order to maintain the immune system in a state of “alert anergia”. The IL-10 
produced acts in an autocrine loop on the same macrophages that express the IL-10 receptor. 
Based on these findings, we analyzed the transcriptional levels of IL-10 and IL-10 receptor in 
bone marrow derived macrophages, spleen Mφ and in the lamina propria Mφ of both WT and 
KO mice in steady-state conditions. We found that no differences were present, between WT 
and KO mice, in any tissue and that macrophages were able to sense IL-10 because STAT-3 
resulted phosphorylated after IL-10 stimulation. These first results revealed that in steady state 
CX3CR1+ Mφ are recruited in the normal mucosa, in both WT and KO mice, and here they 
are able to serve their main role of maintenance of homeostasis producing an equal amount of 
IL-10 and being able to sense it.  
99 
 
How the mucosal macrophages reach the colonic mucosa is still unclear. Bain et al., 
{Bain, 2014 #251}proposed that Ly6Chi monocytes are the precursors of both resident and 
inflammatory macrophages. Here we demonstrated that loss of CX3CR1 receptor does not 
impair the accumulation of resident macrophages in the resting mucosa. The current hypothesis 
is that macrophages are constantly replenished by CCR2+ monocytes and in the mucosa they 
upregulate CX3CR1, acquiring their anti-inflammatory properties.  
Very few and controversial studies have been reported about the role of CX3CR1+ 
macrophages in acute colitis. Two studies unveiled different results, Kostadinova et al. 
analyzed the behavior of CX3CR1+ Mφ in Balb/c mice and suggested a negative role of the 
CX3CL1-CX3CR1 axis in colonic protection. They argued that the ligand-receptor axis 
induces the production of iNOS that they considered the main trigger of inflammation [116]. 
In contrast, Medina-Contreras et al. showed in C57BL/6 mice that the absence of the receptor 
provokes a higher bacteria translocation in the mesenteric lymph nodes (mLN) resulting in 
higher tissue damage during experimental colitis. Their results reveal that both CX3CL1 and 
CX3CR1 KO mice failed to accumulate macrophages in the intestinal mucosa and this results 
in an increased activation of Th17 lymphocytes via IL-17, in addition to a higher translocation 
of commensal bacteria in the mLN. After the administration of DSS, KO mice displayed higher 
signs of CD4-mediated inflammation compared to WT [26]. Our results are consistent with 
the data obtained by Medina-Contreras. In our colitis experiments, we observed more 
inflammation in KO mice, in terms of both histological parameters and quantification of soluble 
mediators. In contrast to the observations made by M-C, we found higher accumulation of 
macrophages and, in particular, of CX3CR1 Mφ in the colonic mucosa of CX3CR1 KO mice. 
As mentioned above, in the lamina propria, CX3CR1+ macrophages are involved in the 
maintenance of homeostasis. Weber and colleagues hypothesized that even during 
inflammation, CX3CR1+ Mφ are able to maintain their anti-inflammatory behavior, avoiding 
the rise of chronic inflammation [12]. Our results are consistent with this hypothesis: KO mice 
failed in maintaining homeostasis because of CX3CR1 loss and, consequently, recruit more 
macrophages in the attempt to switch off inflammation.  
Considering the role of CX3CR1+ Mφ in steady state, we next analyzed their behavior 
in the process of recovery from colitis. The evaluation of weight revealed that at day 10, WT 
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mice began to recover from colitis and at day 13, they had completely restored their original 
phenotype. In contrast, KO mice were unable to recover and displayed, even at day 13, high 
signs of inflammation with a marked reduction in colon length. At day 10, both monocytes and 
macrophages were more abundant in the mucosa of KO mice. The characterization of the 
inflammatory mediators released in the microenvironment was performed as mRNA 
quantification: while WT mice were able to switch off inflammation, KO mice failed in this 
process and over-expressed all the pro-inflammatory mediators up to day 13. We then 
measured IL-10, which is the key regulator of inflammation and the hallmark of CX3CR1+ 
macrophages [8, 30, 34]. We found that KO mice were able to produce even more IL-10 than 
WT mice. This finding indicated that IL-10 production is not dependent from the CX3CL1-
CX3CR1 axis. Our hypothesis is that, due to the higher amounts of inflammatory cytokines, 
KO macrophages respond to this disequilibrium by producing higher levels of IL-10, in an 
attempt to restore homeostasis. However, this does not occur, and this result suggests that loss 
of the receptor and consequently its signaling, has a profound impact on the macrophage 
control of the mucosa.  
Considering this point, we further investigated why loss of receptor leads to higher 
inflammation in KO mice. We found that the only molecule down-regulated in KO mice at 
day 10 was heme-oxygenase-1. Intestinal macrophages have high bactericidal properties [24] 
and hemox-1 is a key regulator of phagocytosis. Hemox-1 is reported to be an anti-
inflammatory molecule, regulated by many factors, including IL-10 [65]. Many studies suggest 
a synergism between IL-10 and the microbiome in the induction of hemox-1 [60], [68, 69]. It 
seems that the microbiome stimulates hemox-1 production via IL-10, and the consequent CO 
formation is able to stimulate bacteria clearance by macrophages. Moreover, Inui et al [152] 
reported that CXRCR1+ Mφ could produce hemox-1 in a model of inflammation induced by 
toxin A. Our results obtained in a model of recovery of colitis unveil that at day 10, when WT 
mice began to restore, there is a strong decrease of hemox-1 in KO mice, both as mRNA and 
protein levels, electing it as a key molecule in CX3CR1 Mφ for the control of colonic 
inflammation. Lee demonstrated that induction of hemox-1 is dose-dependently induced by 
IL-10. In our study we demonstrate that IL-10 production is not sufficient: KO mice are in fact 
able to provide IL-10, but they failed to produce a relevant amount of hemox-1. These results 
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suggested the importance of a correct CX3CL1-CX3CR1 signaling in the modulation of 
hemox-1.  
To deeper investigate the role of hemox-1 in this context and the potential involvement 
of the receptor CX3CR1, we moved in vitro and reproduced the inflammatory conditions 
observed in vivo. We FACS-sorted CX3CR1+ BMDM and stimulated them with LPS and/or 
FKN, obtaining the same results of the in vivo model of colitis. Indeed, after stimulation with 
LPS we detected more pro-inflammatory mediators in KO mice compared to WT. LPS and 
FKN synergized in the production of hemox-1 in WT but not in KO mice; most importantly, 
stimulation with FKN alone was sufficient to produce Hemox-1 in WT mice, unveiling a 
previously unidentified role of the chemokine receptor CX3CR1 in the regulation of Hemox-
1. Even in an experiment of prolonged LPS stimulation (trying to mimic the process of 
recovery from colitis) we observed up-regulation of hemox-1 production in WT mice but not 
in KO mice.  
These in vitro results overall confirm the data obtained in vivo with the DSS model of 
acute colitis, with higher inflammatory mediators and lower hemox-1 in KO mice. The ability 
of our CX3CR1+ macrophages to respond to LPS is in contrast with the previous observation 
by Bain et al. [10]. In their study, they demonstrated that CX3CR1+ macrophages are 
unresponsive to TLR stimulation and the Authors considered this a key feature for the 
maintenance of homeostasis in the colonic mucosa. A possible explanation for the different 
results might be the presence, in the inflamed colonic mucosa, of a population expressing 
intermediate levels of CX3CR1 (CX3CR1INT), recently recruited from circulating monocytes. 
The cells upon inflammation are able to exert pro-inflammatory features; further on, 
CX3CR1+ macrophages expand and begin to recover the tissue [10].  
Furthermore, in the vitro experiment, BMDM from KO mice showed an increment in 
the expression and production of IL-10, retracing the behavior observed in vivo. Overall, we 
demonstrated both in vivo and in vitro the same attitude of CX3CR1 macrophages. In WT 
mice these macrophages maintain the homeostasis, they correctly respond to inflammatory 
stimuli being able to induce inflammation but also to restore the steady state at the end of the 
inflammation. In contrast, KO mice respond to inflammatory stimuli with higher levels of pro-
inflammatory mediators and are not able to recover at the end of the inflammatory insult. KO 
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mice respond to inflammation also by up-regulating IL-10 in order to switch off the aberrant 
response, but this appears a useless attempt. Moreover the impaired production of hemox-1 
results in a prolonged tissue damage.  
Considering the behavior of CX3CR1 macrophages in acute colitis and in the recovery 
from colitis, and considering that tumor is a “wound that fails to heal”, we decided to investigate 
the role of CX3CR1+ Mφ in the development of colorectal cancer, a study that has never been 
performed, to the best of our knowledge. We used the AOM-DSS model to induce a colitis-
associated carcinogenesis. Weekly, during the experiment, we assessed D.A.I. score 
considering the loss of weight, the stool consistence and bleeding. Along treatment, in 
correspondence with DSS administration, KO mice showed a higher degree in D.A.I. score. 
Indeed, at the end of the experiment, they displayed a lower survival rate and the histological 
analyses revealed higher signs of inflammation in terms of colitis score and shortness of the 
colon. The most relevant result was the higher polyps formation in KO mice in comparison to 
WT. In line with the model of acute colitis, we detected more CX3CR1+ macrophages and 
Ly6C+ monocytes in the polyps of KO mice. Moreover, we analyzed the composition of 
macrophages at the tumor border and we demonstrated that the newly recruited macrophages 
entering the tissue are not CX3CR1+, while those that have already reached the tissue express 
the receptor. These data confirmed what is already published in the literature about the 
recruitment of macrophages in the colonic mucosa: the current hypothesis is that Ly6C 
monocytes are recruited via CCL2-CCR2 in the tissue where they are able to differentiate in 
resident or pro-inflammatory macrophages in a context-dependent fashion [28] [10].  
Considering the higher level of inflammation and the higher number of polyps detected 
in KO mice compared to WT, we looked at inflammatory cytokines and anti-inflammatory 
mediators in both polyps and inflamed tissues. In both specimens, pro-inflammatory cytokines 
such as IL-1β, IFN-γ and IL-12 were up-regulated in KO mice compared to WT, while other 
mediators, such as TNF-α, IL-6 and COX2 were higher only in the inflamed tissue, suggesting 
that inflammation could be the cause of higher rate of polyps in KO mice. Instead, when we 
looked at anti-inflammatory mediators we obtained the same data of the acute colitis model. 
Indeed, IL10 and IL-10 family members, such as IL-19 and IL-20 were over-expressed in KO 
mice. As discussed above, KO mice are able to produce IL-10 and they try to switch off the 
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aberrant inflammation by expressing these cytokines. In contrast, TGF-β and hemox-1 were 
down-regulated in KO mice, unveiling a central role of these mediators also in polyps 
development. 
Since hemox-1 seemed to be a key regulator of mucosal resident macrophages, we 
decided to enhance its production in KO mice during the AOM-DSS experiment, using a drug 
able to induce hemox-1 in the intestine (coPP). The results we obtained indicated that hemox-
1 is a crucial player in the regulation of intestinal macrophages. The D.A.I. score of both WT 
and KO mice was almost assessed near 0 and they failed in losing weight after DSS treatment. 
These data were confirmed by the histological results: colon length was restored and the colitis 
score was similar to that of untreated mice. Moreover, the percentage of adenomatous tissue 
was drastically decreased. In addition, pro-inflammatory cytokines, such as iNOS, IFN-γ and 
COX-2 were dramatically reduced in coPP-treated mice. Overall, these results demonstrate 
that, upon pharmacological induction of hemox-1, KO mice retrace the same behavior of WT 
mice and the differences between the two populations disappear, revealing the importance of 
hemox-1 production in this context.  
Moreover, we decided to study a genetic model of intestinal tumorigenesis, in order 
to confirm the data obtained with the sporadic model. We crossed mice bearing the APC 
mutation with CX3CR1GFP/+ or CX3CR1GFP/GFP and we fed them with DSS in order to generate 
an inflamed milieu. We were able to demonstrate also in this model that the absence of the 
receptor leads to higher polyps formation in KO mice compared to WT. Colons of KO mice 
were shorter and the D.A.I. score was more severe. Moreover, the colonic mucosa of KO 
mice was infiltrated with a higher number of monocytes and macrophages reflecting the AOM-
DSS model. Finally, also the analysis of the soluble mediators mirrored the data previously 
described. In particular, IL-6 IFN-γ and IL-10 were upregulated in both polyps and inflamed 
mucosa of KO mice, while TGF-β and hemox-1 were significantly reduced in KO mice. 
Hemox-1 acts on macrophages stimulating the processes of phagocytosis. Considering 
the key role of this molecule in this context, we investigated if KO mice are able to phagocytose 
as WT do. The data we obtained revealed an impaired phagocytic ability of KO macrophages. 
Ishida et al., [57] demonstrated that CX3CR1+ Mφ have impaired anti-bacterial functions. 
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They showed that macrophages are normally recruited in both WT and KO mice but if the 
CX3CR1 receptor is lacking, bacterial clearance is reduced. They supposed that CX3CL1 
serves to activate macrophages to induce the expression of NO, TNFα, IL-12, IL-1β. These 
mediators act in a paracrine and autocrine manner on macrophages augmenting their 
bactericidal functions. Here we demonstrated that if the CX3CR1 receptor is lacking, bacterial 
clearance is reduced, but we propose that this is a direct consequence of impaired hemox-1 
production.  
Considering the importance of microbiome in healthy and in chronic diseases such as 
ulcerative colitis or Chron disease, we performed a deep analysis of the intestinal microbiota 
of WT and KO mice treated with the AOM-DSS protocol. We compared stools of mice at 
week 0, at week 2 (after the first cycle of DSS) and at week 10 (at the sacrifice). We sequenced 
16S rRNA gene amplicons obtained from faecal metagenomic DNA and we compared WT and 
KO mice. At day 0, no differences were detected between WT and KO mice. Contrary to 
common thought, during IBD the richness in bacteria species and their diversity is reduced and 
also the stability in the composition of microbiota changes [51]. In line with this evidence, we 
observed a higher richness in the microbiota composition of WT mice, confirming our previous 
results indicating that KO mice displayed a more severe disease. Our preliminary results 
unveiled that at sacrifice three different genera were divergent between WT and KO. 
Bacteroides is a Gram negative genus that includes bacteria associated to health benefit for the 
host [151]. Lachnospira is a member of the Gram positive class Clostridiales; these bacteria are 
considered among the most active components of the intestinal microbiota and represent part 
of the most important intestinal producers of butyrate, a short chain fatty acid that protects the 
mucosa and regulates immune responses in the gut. Akkermansia is a Gram negative bacterium 
able to efficiently degrade intestinal mucins. Among these three genera, only Akkermansia was 
significantly different between WT and KO at sacrifice. As reported by Png [53], Akkermansia 
is impaired during inflammatory bowel diseases. Loss of Akkermansia results in the rise of 
another mucolytic species- Ruminococcus gnavus- that has been associated with the relapse of the 
human disease. Moreover, being the mucus the native habitat of many species of bacteria, its 
alteration results also in a dysregulation of the total microbiome composition [53]. Therefore, 
the dysregulation observed in KO mice may be a consequence of their inability to produce 
hemox-1 and consequently to properly regulate the commensal microbiome. The resulting 
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down-regulation of Akkermansia could be another factor that promotes chronic inflammation 
and, in the absence of the regulation by CX3CR1+ Mφ, ultimately lead to increased tumor 
development.  
Finally, we analysed if the microbiome of WT mice was able to positively influence the 
behaviour of CX3CR1 KO mice. The results obtained with the co-housing experiment 
indicated that the mixed composition of WT and KO microbiome had a positive role in 
controlling tumor development. Indeed the differences between WT and KO mice were 
attenuated in this experimental model: the histological parameters were drastically ameliorated 
in KO mice if compared to a classical AOM-DSS experiment, the D.A.I. score was almost the 
same as in WT mice and the percentage of adenomatous tissue was the same between the two 
strains. In addition, the transcriptome analyses revealed that inflammation was also attenuated 
in KO mice, even if a difference in hemox-1 production remains. These results suggest that 
the WT microbiome exerts a positive effect on the disease of KO mice. However, a microbiota 
profiling of co-housed mice is necessary in order to better clarify this point.  
To summarize, we described a context in which CX3CR1+ macrophages play a crucial 
role thanks to their ability to control homeostasis and tissue inflammation. During 
inflammation FKN is induced by TNF-α and IFN-γ and, when the receptor is present, the 
CX3CL1-CX3CR1 axis is functional. This results in the induction of hemox-1 with consequent 
increased of phagocytosis and anti-inflammatory conditions. The microbiome contributes to 
hemox-1 production in macrophages. If the CX3CR1 receptor is lacking, intestinal Mφ are 
not able to respond to FKN and do not produce sufficient amount of hemox-1; in spite of high 
levels of IL-10, they are unable to switch off inflammation. In this context, the only stimulus 
for hemox-1 production is provided by the microbiome. However, also the microbiome is 
affected by the inadequate levels of hemox-1 that cause impaired phagocytosis and tissue repair. 
Changes of the microbiome lead to dysbiosis and favour chronic inflammation and cancer 
development.  
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Taken together these 
results unveil a new pathway by 
which intestinal macrophages act 
to maintain homeostasis. If the 
CX3CL1-CX3CR1 checkpoint is 
lost, the aberrant inflammation 
could persist and be corroborated 
by a state of dysbiosis. In this 
landscape, chronic inflammation 
can establish and the impaired 
mechanism of resolution could, 
with time, lead to tumor 
development. Finally, we 
confirmed that treatment with the 
chemical compound coPP up-
regulates hemox-1 also in the 
absence of functional CX3CR1 receptor and drastically ameliorates the intestinal disease. 
These findings open a new scenario in the use of hemox-1 inducing drugs to restore a correct 
intestinal homeostasis in a therapeutic context. To this aim further experiments are required 
to validate the mechanism by which these drugs work and to better investigate the microbiome 
composition. 
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